This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
Article Cite This: ACS Omega 2018, 3, 18002−18015
http://pubs.acs.org/journal/acsodf
Metal-Free Synthesis of Functionalized Tetrasubstituted Alkenes by Three-Component Reaction of Alkynes, Iodine, and Sodium Sulfinates Jitan Zhang,* Zhenda Liang, Jun Wang, Ziyi Guo, Changqing Liu, and Meihua Xie* Key Laboratory of Functional Molecular Solids (Ministry of Education), Anhui Key Laboratory of Molecular Based Materials, College of Chemistry and Materials Science, Anhui Normal University, Wuhu 241002, China
ACS Omega 2018.3:18002-18015. Downloaded from pubs.acs.org by 185.14.195.179 on 12/24/18. For personal use only.
S Supporting Information *
ABSTRACT: An operationally simple, efficient, and metal-/ peroxide-free three-component reaction of alkynes, iodine, and sodium sulfinates has been developed for the construction of highly functionalized tetrasubstituted alkenes. Iodo- and sulfonyl-containing tetrasubstituted alkenes, such as vinyl ketones, allylic alcohols, and conjugated enynes, could be obtained regio- and stereoselectively in up to 96% yield.
■
of alkynes with sulfonyl hydrazides.6 Wang et al.7 reported the synthesis of β-iodovinyl sulfones by difunctionalization of alkynes with sulfinic acids and iodine without any metal catalyst. Jiang8 and Sun9 disclosed iodosulfonylation of alkynes with sodium sulfinates and iodine under metal-free conditions, respectively. Despite the synthetic efficiency of these reactions, almost all of these protocols are limited to the synthesis of trisubstituted alkenes from terminal alkynes. Very recently, Reddy and Wang, respectively, reported the stereoselective synthesis of tetrasubstituted alkenes by iodosulfonylation of electron-deficient internal alkynes, where TBHP (3 equiv) is used as oxidant or sulfonylhydrazide is used as the sulfur source.10 Given the importance of tetrasubstituted alkenes and our ongoing interest in the construction of sulfonyl compounds,11 we present herein a convenient and efficient synthesis of iodo- and sulfonyl-contained tetrasubstituted alkenes, e.g., vinyl ketones, allylic alcohols, and conjugated enynes, by three-component reaction of internal alkynes, iodine, and sodium sulfinates under metal- and peroxide-free conditions.
INTRODUCTION Polysubstituted alkenes are widely present in many natural products, biologically active molecules, and pharmaceuticals such as tamoxifen, doxepin, and combretatstatins A,1 as well as among the most useful structural units in organic transformations, such as the generation of quarternary centers by conjugate addition, osmylations, and epoxidations.2 Thus, it was of particular interest to find an effective and convenient protocol to synthesize functionalized polysubstituted alkenes. Despite the fact that numerous methods have been developed for the synthesis of alkenes, access to tetrasubstituted alkenes remains a challenging task for the synthetic community due to the congested nature of the double bond.2d,3 Additionally, new and general strategies that could provide tetrasubstituted alkenes with diverse functional groups for further transformations are in much demand. Owing to the distinctive structure and electronic features of the sulfonyl group, vinylsulfones have broad utilizations as valuable building blocks in medicinal chemistry, materials chemistry, and organic synthesis.4 Among them, halo vinylsulfones are of significant interest because both the vinylsulfone and vinyl halide are versatile functional units in organic synthesis. Therefore, the simultaneous introduction of sulfonyl and halo into alkenes has drawn great attention from chemists. Transition-metal-catalyzed reaction of terminal alkynes with sulfonyl chlorides or sulfonylhydrazides has emerged as a powerful means to construct halo vinylsulfones,5 yet the use of toxic metals makes it limited for wide application. Alternatively, metal-free synthesis of halo vinylsulfones has been developed during recent years. For example, β-iodo vinylsulfones could be synthesized by metal-free iodosulfonylation © 2018 American Chemical Society
■
RESULTS AND DISCUSSION Initially, the reaction of 3-phenyl-1-(p-tolyl)prop-2-yn-1-one and sodium benzenesulfinate was chosen as the model reaction to optimize the reaction conditions. The experimental results were compiled in Table 1. With the treatment of 1.0 equiv of acetylenic ketone (1a), 1.0 equiv of sodium benzenesulfinate Received: October 26, 2018 Accepted: December 3, 2018 Published: December 21, 2018 18002
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015
ACS Omega
Article
Table 1. Optimization of the Reaction Conditionsa
entry
solvent
1 2c 3 4c 5c 6c 7c
EtOAc EtOAc/H2O H2O EtOAc/H2O EtOAc/H2O THF/H2O CH2Cl2/ H2O Toluene/ H2O DMF/H2O DMSO/ H2O EtOAc/H2O EtOAc/H2O EtOAc/H2O EtOAc/H2O EtOAc/H2O
8c 9c 10c 11c 12c 13c 14c 15c
I2 (equiv)
2a (equiv)
T (°C)
time (h)
yield (%)b
1 1 1 1 1 1 1
1 1 1 1.5 2 2 2
r.t. r.t. r.t. r.t. r.t. r.t. r.t.
24 24 24 24 24 24 24
12 28 trace 40 65 40 61
1
2
r.t.
24
57
1 1
2 2
r.t. r.t.
24 24
trace trace
1 1 1 2 0.8
2 2 2 2 2
0 50 reflux reflux reflux
24 19 12 12 12
trace 78 83 82 76
Several commercially available sodium sulfinates 2 such as sodium phenylsulfinate, sodium p-tolylsulfinate, and sodium methanesulfinate could conduct this reaction successfully to give the corresponding products. The substituents in acetylenic ketones or sodium sulfinates had no apparent effect on the reaction. Unfortunately, no desired product was obtained when R1 in acetylenic ketones is alkyl. Allylic alcohols are pervasive in natural products and serve as ubiquitous intermediates in organic synthesis.12 The construction of allylic alcohols has been a focus in methodology development for decades.13 Encouraged by the experimental results of acetylenic ketones, we investigated the similar transformation of propargyl alcohols. The results show that iodosulfonylation reaction can be readily extended to propargyl alcohols. The desired functionalized tetrasubstituted allylic alcohols 5 were isolated in up to 96% yield when propargyl alcohols reacted with 2.0 equiv of sodium sulfinates and 1.5 equiv of iodine in DCE/H2O (v:v = 2:1) at reflux (Table 3). R1 in propargyl alcohols can be p-tolyl (5a−5h, Table 3), phenyl (5i−5o, Table 3), p-methoxyphenyl (5p−5x, Table 3), and p-fluorophenyl (5y and 5z, Table 3), respectively. R2 in propargyl alcohols can be phenyl, n-propyl, and electron-rich and electron-deficient aryl. Similarly, no desired product was obtained when R1 in propargyl alcohols is alkyl. On the other hand, conjugated enynes are of great interest in organic synthesis, materials science, and biochemistry due to their ubiquitous occurrence in bioactive natural products and functional materials.14 Transition-metal-catalyzed cross coupling of vinyl halides or acetylenic halides15 and dimerization of alkynes16 are the most commonly used synthetic methods for access to conjugated enynes. However, direct stereoselective synthesis of highly substituted conjugated enynes from 1,3-diynes is scarce.17 To further demonstrate the synthetic utility of this protocol, we extended the iodosulfonylation reaction to 1,3-diynes. It was found that the reaction proceeded smoothly, and the polysubstituted conjugated enynes 7 were isolated in 48−74% yields when 1,3-diynes 6 reacted with 2 equiv of sodium sulfinates and 1.5 equiv of iodine in DCE/H2O (v:v = 2:1) at reflux (Table 4). The R1 in 1,3-diynes can be phenyl (7a−7c, Table 4), p-methylphenyl (7d−7f, Table 4), p-fluorophenyl (7g−7i, Table 4), pmethoxyphenyl (7j, Table 4), and p-chlorophenyl (7k, Table 4). R2 in sodium sulfinates can be phenyl, methyl, and p-tolyl. Unfortunately, complex mixtures were observed in the case of unsymmetrical 1,3-diynes. The configurations of compounds 3, 5, and 7 were unambiguously confirmed by X-ray crystallographic analysis of 3a, 5c, and 7i (see Supporting Information), indicating that the iodosulfonylation of carbon−carbon triple bond proceeds in anti-fashion. To examine the synthetic application of the obtained functionalized tetrasubstituted alkenes, the palladium-catalyzed Suzuki coupling reaction of the obtained iodo- and sulfonylsubstituted alkenes was investigated. The Suzuki coupling reactions of p-tolylboronic acid with compounds 3a, 5e, and 7b proceeded smoothly, and the desired products 8, 9, and 10 were isolated in excellent yields (Scheme 1). To investigate the reaction mechanism, some control experiments were conducted (Scheme 2). When the radical scavenger TEMPO (2 equiv) was added to the standard reaction conditions, inhibition of the reaction was observed. The desired product 3a was isolated in 56% yield when acetylenic ketone 1a directly reacts with benzenesulfonyl
a
Reaction conditions: 1a (0.5 mmol), 2a, I2, solvent (3 mL). Isolated yields based on 1a. c2 mL of organic solvent and 1 mL of H2O.
b
(2a), and 1.0 equiv of I2 in ethyl acetate at room temperature for 24 h, (E)-3-iodo-3-phenyl-2-(phenylsulfonyl)-1-(p-tolyl)prop-2-en-1-one (3a) could be isolated in 12% yield along with recovery of 1a (entry 1, Table 1). Considering the solubility of sodium sulfinate, ethyl acetate/water (v:v = 2:1) was used as the solvent, and 3a was isolated in 28% yield (entry 2, Table 1). Only a trace of 3a was detected in water (entry 3, Table 1). The yield of 3a was increased to 65% when excess sodium benzenesulfinate was used (entries 4 and 5, Table 1). Screening various solvents suggested ethyl acetate/water (v:v = 2:1) as the best candidate for this reaction (entries 5−10, Table 1). The yield of 3a was further improved to 83% by increasing the reaction temperature to reflux, while only a trace of 3a was detected by performing the reaction at 0 °C (entries 11−13, Table 1). An increase in the amount of I2 has no apparent effect on the yield of 3a, and a reduced amount of I2 was detrimental to the yield (entries 14 and 15, Table 1). Based on these experimental results, we defined that acetylenic ketones react with 2.0 equiv of sodium sulfinates and 1.0 equiv of I2 in ethyl acetate/water (v:v = 2:1) at reflux as the optimal reaction conditions for the scope of study. With the optimized reaction conditions in hand, a range of acetylenic ketones and sodium sulfinates were employed in the reaction to evaluate the scope and generality of this protocol, and results are summarized in Table 2. The reaction worked well with various substituted acetylenic ketones, and the corresponding β-iodo-α-sulfonyl vinyl ketones 3 were obtained in the range of 76%−91% yields. R1 in acetylenic ketones can be phenyl (3a−3j, Table 2), p-tolyl (3k−3o, Table 2), pmethoxyphenyl (3p−3w, Table 2), p-fluorophenyl (3x and 3y, Table 2), and p-chlorophenyl (3z, Table 2), respectively. The compatibility of R2 in acetylenic ketones was also investigated, by revealing that phenyl, electron-rich and electron-deficient aryl, and n-propyl could be well tolerated in the reaction. 18003
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015
ACS Omega
Article
Table 2. Three-Component Reaction of Acetylenic Ketones, Iodine, and Sodium Sulfinatesa
a
Reaction conditions: 1 (0.25 mmol), 2 (0.5 mmol), and I2 (0.25 mmol) in 3 mL of EtOAc/H2O (v:v = 2:1) at reflux. bIsolated yields based on 1.
intermediate B. In the case of acetylenic ketones (or propargyl alcohols), the β-carbonyl (or γ-hydroxyl) vinyl radical intermediate is more stable than the α-carbonyl (or βhydroxyl) vinyl radical intermediate because of the electronwithdrawing effect of carbonyl (or hydroxyl), giving α-sulfonyl vinyl ketones (or β-sulfonyl allylic alcohols). In the case of 1,3diynes, the α-alkynyl vinyl radical intermediate is more stable than the β-alkynyl vinyl radical intermediate due to the conjugation effects of the carbon−carbon triple bond, affording 2-iodo-1-sulfonyl 1,3-enynes.
iodode under the optimized reaction conditions. The reaction proceeded much faster to provide 89% yield of 3a after 0.5 h when the reaction of acetylenic ketone 1a with benzenesulfonyl iodode was conducted in the presence of 5 mol % of AIBN. On the basis of the experimental results and related literature,7,8 a mechanism for the iodosulfonylation of alkynes is proposed as shown in Scheme 3. First, the sodium sulfinate reacts with iodine to give sulfonyl iodide intermediate, which may undergo homolytic cleavage to yield a sulfonyl radical A. Addition of A to acetylenic ketone 1a chemoselectively generates the more stable vinyl radical intermediate B. Subsequently, vinyl radical B reacts with sulfonyl iodide, I2, or iodine radical to afford the functionalized alkenes 3. The regioselectivity of the reaction may be determined by the stability of the vinyl radical
■
CONCLUSION In summary, we have developed a convenient and general method for the construction of highly functionalized 18004
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015
ACS Omega
Article
Table 3. Three-Component Reaction of Propargyl Alcohols, Iodine, and Sodium Sulfinatesa
a Reaction conditions: 4 (0.25 mmol), 2 (0.5 mmol), and I2 (0.375 mmol) in 3 mL of ClCH2CH2Cl/H2O (v:v = 2:1) at reflux. bIsolated yields based on 4.
tetrasubstituted alkenes, e.g., iodo- and sulfonyl-substituted vinyl ketones, allylic alcohols, and conjugated enynes, from three-component reaction of acetylenic ketones, propargyl alcohols, or 1,3-diynes with iodine and sodium sulfinates. The method is characterized by its wide substrate scope, high regioand stereoselectivity, mild reaction conditions, and readily available starting materials. It is predictable that the resulting
highly functionalized alkenes are potential precursors for differently tetrasubstituted alkenes.
■
EXPERIMENTAL SECTION General Information. Unless otherwise stated, all commercial materials and solvents were used directly without further purification. 1H NMR and 13C NMR spectra were recorded on a 300 or 500 MHz spectrometer (1H at 300 MHz, 18005
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015
ACS Omega
Article
Table 4. Three-Component Reaction of 1,3-Diynes, Iodine, and Sodium Sulfinatesa
a Reaction conditions: 6 (0.25 mmol), 2 (0.5 mmol), and I2 (0.375 mmol) in 3 mL of ClCH2CH2Cl/H2O (v:v = 2:1) at reflux. bIsolated yield based on 6.
Scheme 1. Pd-Catalyzed Suzuki Coupling Reactions of 3a, 5e, and 7b with p-Tolylboronic Acid
Scheme 2. Control Experiment
Scheme 3. Possible Reaction Mechanism
internal standard at room temperature. Chemical shifts are given in δ relative to TMS, and the coupling constants (J) are given in hertz. The multiplicities are reported as follows: singlet (s), doublet (d), multiplet (m), triplet (t), and broad resonances (br). High-resolution mass spectra were recorded on an Agilent model G6220 mass spectrometer. All reactions under a nitrogen atmosphere were conducted using standard Schlenk techniques. Melting point data are uncorrected. Typical Experimental Procedure for the Synthesis of Propargyl Alcohols 4 and Acetylenic Ketones 1.18
13
C at 75 MHz or 1H at 500 MHz, 13C at 125 MHz), using CDCl3 as the solvent with tetramethylsilane (TMS) as an 18006
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015
ACS Omega
Article
146.4, 140.8, 140.4, 134.0, 131.8, 130.8, 130.4, 129.9, 129.1, 128.7, 128.4, 127.9, 114.4, 22.4. IR (KBr, ν, cm−1): 3055, 2920, 2360, 1666, 1600, 1446, 1303, 1145, 781, 551. HRMS m/z (ESI) calcd for C22H18IO3S (M + H)+ 489.0016, found 489.0016. (E)-3-Iodo-3-phenyl-1-(4-tolyl)-2-tosylprop-2-en-1-one (3b). White solid; mp 151−152 °C; yield 78%. 1H NMR (300 MHz, CDCl3): δ 8.13 (d, J = 9.0 Hz, 2H), 7.39 (d, J = 9.0 Hz, 2H), 7.34−7.28 (m, 5H), 7.18−7.10 (m, 4H), 2.49 (s, 3H), 2.38 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 190.7, 149.9, 146.3, 145.2, 140.5, 137.9, 131.8, 130.8, 130.4, 129.9, 129.7, 128.9, 128.3, 127.9, 113.9, 22.4, 22.1. IR (KBr, ν, cm−1): 3049, 2918, 1668, 1602, 1323, 1255, 1151, 1082, 773, 565, 545. HRMS m/z (ESI) calcd for C23H20IO3S (M + H)+ 503.0172, found 503.0167. (E)-3-Iodo-2-(methylsulfonyl)-3-phenyl-1-(4-tolyl)prop-2en-1-one (3c). White solid; mp 159−160 °C; yield 77%. 1H NMR (300 MHz, CDCl3): δ 8.08 (d, J = 8.2 Hz, 2H), 7.50− 7.45 (m, 4H), 7.42−7.37 (m, 3H), 2.91 (s, 3H), 2.48 (s, 3H). 13 C NMR (125 MHz, CDCl3): δ 191.0, 147.6, 146.6, 140.8, 131.4, 130.9, 130.5, 128.7, 127.6, 115.1, 44.8, 22.4. IR (KBr, ν, cm−1): 3003, 2920, 1668, 1600, 1323, 1255, 1138, 964, 783, 513, 480. HRMS m/z (ESI) calcd for C17H16IO3S (M + H)+ 426.9859, found 426.9859. (E)-3-Iodo-1-(4-methoxyphenyl)-3-phenyl-2(phenylsulfonyl)prop-2-en-1-one (3d). White solid; mp 135− 136 °C; yield 80%. 1H NMR (300 MHz, CDCl3): δ 8.22 (d, J = 8.8, 2H), 7.55−7.46 (m, 3H), 7.35−7.28 (m, 5H), 7.14− 7.07 (m, 4H), 3.94 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 189.5, 165.3, 149.9, 140.9, 140.5, 134.0, 133.2, 129.9, 129.1, 128.7, 128.4, 127.9, 127.3, 115.1, 114.3, 56.1. IR (KBr, ν, cm−1): 2839, 1660, 1593, 1573, 1315, 1253, 1166, 1026, 840, 748, 540. HRMS m/z (ESI) calcd for C22H18IO4S (M + H)+ 504.9965, found 504.9966. (E)-1-Iodo-1-phenyl-2-(phenylsulfonyl)hex-1-en-3-one (3e). White solid; mp 97−98 °C; yield 76%. 1H NMR (300 MHz, CDCl3): δ 7.51 (t, J = 4.5 Hz, 1H), 7.40−7.39 (m, 2H), 7.31 (t, J = 4.5 Hz, 2H), 7.26−7.25 (m, 1H), 7.21 (t, J = 7.4 Hz, 2H), 7.02 (d, J = 4.4 Hz, 2H), 3.10 (t, J = 4.3 Hz, 2H), 1.89−1.82 (m, 2H), 1.07 (t, J = 4.5 Hz, 3H). 13C NMR (125 MHz, CDCl3): δ 200.3, 151.1, 140.6, 140.1, 134.1, 129.9, 129.2, 128.5, 128.3, 127.8, 112.2, 44.9, 17.1, 13.9. IR (KBr, ν, cm−1): 3021, 1677, 1523, 1157, 832, 755, 643. HRMS m/z (ESI) calcd for C18H18IO3S (M + H)+ 441.0016, found 441.0023. (E)-1-(4-Fluorophenyl)-3-iodo-3-phenyl-2(phenylsulfonyl)prop-2-en-1-one (3f). White solid; mp 146− 147 °C; yield 91%. 1H NMR (300 MHz, CDCl3): δ 8.30−8.26 (m, 2H), 7.56−7.45 (m, 3H), 7.36−7.29 (m, 7H), 7.13 (d, J = 6.0 Hz, 2H). 13C NMR (125 MHz, CDCl3): δ 189.5, 167.2 (d, J = 257 Hz), 149.5, 140.7, 140.2, 134.2, 133.4 (d, J = 9.7 Hz), 130.8, 130.1, 129.2, 128.7, 128.4, 127.8, 117.0 (d, J = 22.1 Hz), 114.9. IR (KBr, ν, cm−1): 3068, 1676, 1595, 1319, 1234, 1145, 1078, 848, 686, 547. HRMS m/z (ESI) calcd for C21H15FIO3S (M + H)+ 492.9765, found 492.9760. (E)-1-(4-Chlorophenyl)-3-iodo-3-phenyl-2(phenylsulfonyl)prop-2-en-1-one (3g). White solid; mp 141− 142 °C; yield 88%. 1H NMR (300 MHz, CDCl3): δ 8.18 (d, J = 8.5 Hz, 2H), 7.60−752 (m, 3H), 7.46 (d, J = 7.3 Hz, 2H), 7.36−7.25 (m, 5H), 7.13 (d, J = 7.2 Hz, 2H). 13C NMR (125 MHz, CDCl3): δ 189.8, 149.3, 141.8, 140.6, 140.1, 134.2, 132.7, 132.0, 130.1, 129.2, 128.7, 128.4, 127.8, 115.1. IR (KBr, ν, cm−1): 3091, 3057, 1668, 1585, 1442, 1330, 1152, 1083,
Alkyne (6.00 mmol, 1.20 equiv) and anhydrous THF (15 mL) were added to a 50 mL two-neck round-bottom flask. The mixture was cooled to 0 °C, and n-BuLi (2.5 M in hexanes, 2.50 mL, 6.25 mmol, 1.25 equiv) was added slowly via syringe. The mixture was stirred at 0 °C for 1 h and then at room temperature for 1 h and then recooled to 0 °C. Aldehyde (5.00 mmol) in THF (5 mL) was added dropwise via syringe. The reaction was stirred at 0 °C for 1 h and then at room temperature for an additional 30 min. Upon the completion of the reaction, the reaction was quenched with saturated aqueous NH4Cl and extracted with ethyl acetate. The combined organic extracts were washed with brine (50 mL) and dried over anhydrous Na2SO4. After filtration and removal of the solvent under reduced pressure, the residue was purified by flash column chromatography (silica gel, petroleum ether/ ethyl acetate = 10/1) to afford the desired propargyl alcohol 4. MnO2 (15 equiv) was added to a solution of propargyl alcohol 4 (5 mmol) in CH2Cl2 (15 mL) at room temperature, and the resulting mixture was stirred overnight. Then the solid was filtered, and the solvents were removed under reduced pressure. The residue was purified by flash column chromatography (silica gel, petroleum ether/ethyl acetate = 50/1) to give acetylenic ketone 1. Typical Experimental Procedure for the Synthesis of 1,3-Diynes 6.19 In the open air, alkyne (3.0 mmol) and Cu(OAc)2·H2O (0.3 mmol) were added to a 100 mL tube successively. Then the tube was sealed, and the resulting mixture was allowed to react at 110 °C for 7 h. After completion of the reaction, 30 mL of ethyl acetate was added. The mixture was filtered, and the filtration residue was washed with ethyl acetate. Ethyl acetate was removed under reduced pressure, and the residue was purified by column chromatography (silica gel, petroleum ether as eluent) to afford the 1,3diyne 6. Typical Experimental Procedure for the Synthesis of PhSO2I.4a A saturated solution of iodine (2.0 g, 8.0 mmol) in alcohol (7 mL) was added gradually to the solution of sodium benzenesulfinate (1.6 g, 10 mmol) in 35 mL of distilled water until a slight excess of iodine was present. During this period, the yellow precipitate was formed gradually. The precipitate was filtered, washed with cold water, and dried carefully at room temperature to give benzenesulfonyl iodide as a yellow solid. Typical Experimental Procedure for the Synthesis of Functionalized Tetrasubstituted Vinyl Ketones 3. Under argon atmosphere, a Schlenk flask equipped with a condenser was charged with 0.25 mmol (55 mg) of 3-phenyl-1-(ptolyl)prop-2-yn-1-one (1a), 0.5 mmol (82 mg) of sodium benzenesulfinate (2a), 0.25 mmol (64 mg) of I2, and 3 mL of ethyl acetate/H2O (v/v 2/1). The reaction mixture was stirred at reflux until the complete consumption of 1a (monitored by TLC). The reaction was then quenched with saturated NH4Cl and extracted with ethyl acetate (3 × 15 mL). The organic layer was washed with saturated Na2S2O3 and dried over anhydrous Na2SO4. After filtration and removal of the solvent in vacuo, the crude product was purified by flash column chromatography on silica gel (silica gel, petroleum ether/ethyl acetate = 15/1) to give product 3a. (E)-3-Iodo-3-phenyl-2-(phenylsulfonyl)-1-(4-tolyl)prop-2en-1-one (3a). White solid; mp 167−168 °C; yield 83%. 1H NMR (300 MHz, CDCl3): δ 8.15 (d, J = 8.0 Hz, 2H), 7.55− 7.40 (m, 5H), 7.35−7.29 (m, 5H), 7.14 (d, J = 6.4 Hz, 2H), 2.50 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 190.6, 149.8, 18007
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015
ACS Omega
Article
2H), 7.59−7.46 (m, 5H), 7.34 (t, J = 7.5 Hz, 2H), 7.10−7.03 (m, 4H), 2.39 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 189.9, 148.9, 141.7, 140.7, 140.5, 137.4, 134.2, 132.8, 132.0, 130.1, 129.1, 129.0, 128.8, 127.8, 115.7, 21.8. IR (KBr, ν, cm−1): 3080, 3030, 1681, 1581, 1301, 1141, 1080, 817, 732, 682, 543. HRMS m/z (ESI) calcd for C 22H17ClIO 3S (M + H) + 522.9626, found 522.9622. (E)-1-(2-Bromophenyl)-3-iodo-2-(phenylsulfonyl)-3-(4tolyl)prop-2-en-1-one (3o). Yellow solid; mp 136−137 °C; yield 78%. 1H NMR (300 MHz, CDCl3): δ 8.23 (d, J = 7.7 Hz, 1H), 7.79 (d, J = 7.8 Hz, 1H), 7.58−7.44 (m, 5H), 7.36 (t, J = 7.5 Hz, 2H), 7.10−7.00 (m, 4H), 2.39 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 189.6, 149.3, 141.0, 140.4, 137.6, 136.0, 134.5, 134.4, 134.1, 133.9, 129.1, 128.9, 128.8, 128.1, 127.7, 124.0, 116.3, 21.9. IR (KBr, ν, cm−1): 3066, 3030, 1683, 1583, 1444, 1319, 1228, 1151, 1020, 785, 684, 559, 540. HRMS m/z (ESI) calcd for C22H17BrIO3S (M + H)+ 566.9121, found 566.9117. (E)-3-Iodo-3-(4-methoxyphenyl)-1-phenyl-2(phenylsulfonyl)prop-2-en-1-one (3p). White solid; mp 111− 112 °C; yield 84%. 1H NMR (300 MHz, CDCl3): δ 8.24 (d, J = 7.4 Hz, 2H), 7.70 (t, J = 7.2 Hz, 1H), 7.62−7.48 (m, 5H), 7.34 (t, J = 7.4 Hz, 2H), 7.13 (t, J = 8.7 Hz, 2H), 6.78 (d, J = 8.7 Hz, 2H), 3.85 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 191.1, 161.0, 149.2, 140.9, 135.1, 134.3, 134.1, 132.6, 130.7, 129.8, 129.6, 129.1, 128.7, 115.4, 113.8, 55.9. IR (KBr, ν, cm−1): 3059, 2918, 1662, 1604, 1319, 1305, 1251, 1149, 1085, 823, 736, 582, 528. HRMS m/z (ESI) calcd for C22H18IO4S (M + H)+ 504.9965, found 504.9965. (E)-3-Iodo-3-(4-methoxyphenyl)-2-(phenylsulfonyl)-1-(4tolyl)prop-2-en-1-one (3q). White solid; mp 176−177 °C; yield 85%. 1H NMR (300 MHz, CDCl3): δ 8.13 (d, J = 8.1 Hz, 2H), 7.54−7.49 (m, 3H), 7.41−7.31 (m, 4H), 7.12 (d, J = 8.7 Hz, 2H), 6.77 (d, J = 8.8 Hz, 2H), 3.85 (s, 3H), 2.48 (s, 3H). 13 C NMR (125 MHz, CDCl3): δ 190.7, 160.9, 149.4, 146.3, 140.9, 134.0, 132.7, 131.9, 130.8, 130.4, 129.8, 129.1, 128.7, 115.1, 113.7, 55.9, 22.4. IR (KBr, ν, cm−1): 3063, 2833, 1668, 1504, 1307, 1250, 823, 559, 540. HRMS m/z (ESI) calcd for C23H20IO4S (M + H)+ 519.0121, found 519.0118. (E)-3-Iodo-3-(4-methoxyphenyl)-2-(phenylsulfonyl)-1-(2tolyl)prop-2-en-1-one (3r). Yellow solid; mp 152−153 °C; yield 77%. 1H NMR (300 MHz, CDCl3): δ 8.21 (d, J = 7.4 Hz, 1H), 7.53−7.41 (m, 5H), 7.35−7.30 (m, 3H), 7.09 (d, J = 8.2 Hz, 2H), 6.75 (d, J = 8.3 Hz, 2H), 3.83 (s, 3H), 2.72 (s, 3H). 13 C NMR (125 MHz, CDCl3): δ 192.3, 160.9, 150.4, 142.6, 141.0, 134.0, 133.2, 133.1, 132.9, 132.6, 129.9, 129.0, 128.6, 126.7, 115.0, 113.7, 55.9, 22.6. IR (KBr, ν, cm−1): 3007, 2843, 1674, 1321, 1151, 1033, 832, 555, 538. HRMS m/z (ESI) calcd for C23H20IO4S (M + H)+ 519.0121, found 519.0126. (E)-3-Iodo-1,3-bis(4-methoxyphenyl)-2-(phenylsulfonyl)prop-2-en-1-one (3s). White solid; mp 136−137 °C; yield 84%. 1H NMR (300 MHz, CDCl3): δ 8.20 (d, J = 8.9 Hz, 2H), 7.54−7.49 (m, 3H), 7.34 (t, J = 7.1 Hz, 2H), 7.13−7.05 (m, 4H), 6.76 (d, J = 8.8 Hz, 2H), 3.93 (s, 3H), 3.84 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 189.6, 165.3, 160.9, 149.4, 140.9, 133.9, 133.2, 132.8, 129.8, 129.0, 128.7, 127.4, 115.0, 113.7, 56.1, 55.9. IR (KBr, ν, cm−1): 2931, 2837, 1660, 1593,1504, 1259, 1168, 1024, 829, 557, 543. HRMS m/z (ESI) calcd for C23H20IO5S (M + H)+ 535.0071, found 535.0066. (E)-1-(4-Chlorophenyl)-3-iodo-3-(4-methoxyphenyl)-2(phenylsulfonyl)prop-2-en-1-one (3t). White solid; mp 163− 164 °C; yield 90%. 1H NMR (300 MHz, CDCl3): δ 8.17 (d, J = 8.4 Hz, 2H), 7.59−7.48 (m, 5H), 7.35 (t, J = 7.5 Hz, 2H),
844, 684, 553, 540. HRMS m/z (ESI) calcd for C21H15ClIO3S (M + H)+ 508.9470, found 508.9467. (E)-1-(4-Chlorophenyl)-3-iodo-3-phenyl-2-tosylprop-2-en1-one (3h). White solid; mp 159−160 °C; yield 81%. 1H NMR (300 MHz, CDCl3): δ 8.17 (d, J = 8.6 Hz, 2H), 7.57 (d, J = 8.6 Hz, 2H), 7.33−7.29 (m, 5H), 7.17−7.12 (m, 4H), 2.39 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 189.9, 149.4, 145.4, 141.7, 140.3, 137.6, 132.7, 131.9, 130.0, 129.8, 128.9, 128.4, 127.8, 114.6, 22.1. IR (KBr, ν, cm−1): 3064, 2920, 1676, 1583, 1323, 1255, 1151, 1082, 844, 698, 545. HRMS m/z (ESI) calcd for C22H17IClO3S (M + H)+ 522.9626, found 522.9625. (E)-1-(4-Chlorophenyl)-3-iodo-2-(methylsulfonyl)-3-phenylprop-2-en-1-one (3i). White solid; mp 157−158 °C; yield 80%. 1H NMR (300 MHz, CDCl3): δ 8.11 (d, J = 8.5 Hz, 2H), 7.56 (d, J = 8.5 Hz, 2H), 7.47−7.40 (m, 5H), 2.92 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 190.3, 147.2, 141.9, 140.5, 132.3, 132.0, 130.6, 130.1, 128.8, 127.5, 115.8, 44.9. IR (KBr, ν, cm−1): 2997, 2914, 1670, 1583, 1323, 1143, 964, 839, 778, 511, 399. HRMS m/z (ESI) calcd for C16H13ClIO3S (M + H)+ 446.9313, found 446.9313. (E)-1-(4-Bromophenyl)-3-iodo-3-phenyl-2(phenylsulfonyl)prop-2-en-1-one (3j). White solid; mp 144− 145 °C; yield 85%. 1H NMR (300 MHz, CDCl3): δ 8.10 (d, J = 8.5 Hz, 2H), 7.76 (d, J = 8.5 Hz, 2H), 7.54 (t, J = 7.3 Hz, 1H), 7.46−7.44 (m, 2H), 7.36−7.29 (m, 5H), 7.13 (d, J = 6.6 Hz, 2H). 13C NMR (125 MHz, CDCl3): δ 190.1, 149.3, 140.6, 140.1, 134.2, 133.1, 132.0, 130.7, 130.1, 129.2, 128.7, 128.4, 127.8, 115.1. IR (KBr, ν, cm−1): 3068, 1672, 1581, 1325, 1240, 1153, 1083, 835, 779, 732, 549. HRMS m/z (ESI) calcd for C21H15BrIO3S (M + H)+ 552.8964, found 552.8963. (E)-3-Iodo-1-phenyl-2-(phenylsulfonyl)-3-(4-tolyl)prop-2en-1-one (3k). White solid; mp 136−137 °C; yield 86%. 1H NMR (300 MHz, CDCl3): δ 8.24 (d, J = 7.4 Hz, 2H), 7.70 (t, J = 7.2 Hz, 1H), 7.63−7.48 (m, 5H), 7.33 (t, J = 7.5 Hz, 2H), 7.07 (s, 4H), 2.39 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 191.0, 149.3, 140.8, 140.4, 137.6, 135.1, 134.3, 134.1, 130.7, 129.6, 129.1, 129.0, 128.8, 127.9, 115.3, 21.8. IR (KBr, ν, cm−1): 3041, 2922, 1681, 1593, 1504, 1446, 1323, 1151, 788, 684, 555, 540; HRMS m/z (ESI) calcd for C22H18IO3S (M + H)+ 489.0016, found 489.0010. (E)-3-Iodo-2-(phenylsulfonyl)-1,3-di-4-tolylprop-2-en-1one (3l). White solid; mp 168−169 °C; yield 84%. 1H NMR (300 MHz, CDCl3): δ 8.13 (d, J = 8.1 Hz, 2H), 7.55−7.48 (m, 3H), 7.41−7.30 (m, 4H), 7.06 (s, 4H), 2.49 (s, 3H), 2.38 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 190.6, 149.4, 146.4, 140.9, 140.3, 137.7, 134.0, 131.9, 130.8, 130.4, 129.1, 129.0, 128.8, 127.9, 115.0, 22.4, 21.8. IR (KBr, ν, cm−1): 3028, 2920, 1676, 1598, 1301, 1141, 1080, 815, 727, 553, 542. HRMS m/z (ESI) calcd for C23H20IO3S (M + H)+ 503.0172, found 503.0169. (E)-3-Iodo-1-(4-methoxyphenyl)-2-(phenylsulfonyl)-3-(4tolyl)prop-2-en-1-one (3m). White solid; mp 153−154 °C; yield 82%. 1H NMR (300 MHz, CDCl3): δ 8.21 (d, J = 8.7 Hz, 2H), 7.55−7.48 (m, 3H), 7.32 (t, J = 7.6 Hz, 2H), 7.08−7.06 (m, 6H), 3.94 (s, 3H), 2.38 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 189.5, 165.3, 149.5, 140.9, 140.2, 137.8, 134.0, 133.1, 129.0, 128.8, 127.8, 127.4, 115.0, 56.1, 21.8. IR (KBr, ν, cm−1): 3018, 2846, 1647, 1589, 1315, 1261, 1165, 1147, 1020, 837, 549, 470. HRMS m/z (ESI) calcd for C23H20IO4S (M + H)+ 519.0121, found 519.0115. (E)-1-(4-Chlorophenyl)-3-iodo-2-(phenylsulfonyl)-3-(4tolyl)prop-2-en-1-one (3n). White solid; mp 174−175 °C; yield 89%. 1H NMR (300 MHz, CDCl3): δ 8.17 (d, J = 8.5 Hz, 18008
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015
ACS Omega
Article
7.11 (d, J = 8.6 Hz, 2H), 6.78 (d, J = 8.6 Hz, 2H), 3.85 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 190.0, 161.1, 148.8, 141.7, 140.7, 134.2, 132.8, 132.4, 132.0, 130.1, 129.8, 129.1, 128.7, 115.8, 113.8, 55.9. IR (KBr, ν, cm−1): 3063, 2835, 1672, 1600, 1504, 1258, 1149, 1082, 827, 543. HRMS m/z (ESI) calcd for C22H17ClIO4S (M + H)+ 538.9575, found 538.9572. (E)-1-(2-Chlorophenyl)-3-iodo-3-(4-methoxyphenyl)-2(phenylsulfonyl)prop-2-en-1-one (3u). Yellow solid; mp 132−133 °C; yield 78%. 1H NMR (300 MHz, CDCl3): δ 8.22 (d, J = 7.4 Hz, 1H), 7.57−7.48 (m, 6H), 7.37 (t, J = 7.2 Hz, 2H), 7.10 (d, J = 8.7 Hz, 2H), 6.78 (d, J = 8.7 Hz, 2H), 3.85 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 189.3, 161.0, 149.5, 141.1, 135.7, 134.6, 134.1, 133.7, 133.1, 132.5, 132.4, 129.7, 129.1, 128.8, 127.6, 115.7, 113.7, 55.9. IR (KBr, ν, cm−1): 3007, 1683, 1604, 1506, 1321, 1259, 1033, 831, 786, 557. HRMS m/z (ESI) calcd for C22H17ClIO4S (M + H)+ 538.9575, found 538.9578. (E)-1-(4-Chlorophenyl)-3-iodo-3-(4-methoxyphenyl)-2-tosylprop-2-en-1-one (3v). Yellow solid; mp 175−176 °C; yield 85%. 1H NMR (300 MHz, CDCl3): 8.16 (d, J = 8.5 Hz, 2H), 7.56 (d, J = 8.5 Hz, 2H), 7.35 (d, J = 8.2 Hz, 2H),7.14 (d, J = 8.4 Hz, 2H), 6.80 (d, J = 8.7 Hz, 2H), 3.87 (s, 3H), 2.39 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 190.0, 161.1, 148.9, 145.4, 141.6, 137.8, 132.8, 132.5, 132.0, 130.0, 129.8, 129.7, 128.8, 115.3, 113.7, 55.9, 22.1. IR (KBr, ν, cm−1): 2980, 2839, 1672, 1583, 1325, 1083, 833, 543, 524. HRMS m/z (ESI) calcd for C23H19ClIO4S (M + H)+ 552.9732, found 552.9735. (E)-1-(4-Chlorophenyl)-3-iodo-3-(4-methoxyphenyl)-2(methylsulfonyl)prop-2-en-1-one (3w). White solid; mp 177−178 °C; yield 82%. 1H NMR (300 MHz, CDCl3): δ 8.11 (d, J = 8.5 Hz, 2H), 7.55 (d, J = 8.6 Hz, 2H), 7.46 (d, J = 8.8 Hz, 2H), 6.95 (d, J = 8.8 Hz, 2H), 3.86 (s, 3H), 2.89 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 190.3, 161.4, 146.7, 141.8, 132.4, 132.0, 130.1, 129.8, 116.4, 114.2, 55.8, 44.7. IR (KBr, ν, cm−1): 3020, 2918, 1668, 1614, 1583, 1506, 1315, 1249, 1139, 960, 835, 530, 499. HRMS m/z (ESI) calcd for C17H15ClIO4S (M + H)+ 476.9419, found 476.9419. (E)-1-(4-Chlorophenyl)-3-(4-fluorophenyl)-3-iodo-2(phenylsulfonyl)prop-2-en-1-one (3x). Yellow solid; mp 163− 164 °C; yield 83%. 1H NMR (300 MHz, CDCl3): δ 8.09 (d, J = 8.5 Hz, 2H), 7.53−7.48 (m, 3H), 7.44−7.41 (m, 2H), 7.34− 7.29 (m, 2H), 7.09−7.05 (m, 2H), 6.90 (t, J = 8.6 Hz, 2H). 13 C NMR (125 MHz, CDCl3): δ 189.7, 163.50 (d, J = 250.4 Hz), 150.0, 141.7, 140.5, 136.2, 134.4 (d, J = 6.2 Hz), 132.6, 131.9, 130.1 (d, J = 8.2 Hz), 129.3, 129.2, 128.7, 115.6 (d, J = 21.9 Hz), 113.6. IR (KBr, ν, cm−1): 3105, 3066, 1666, 1585, 1502, 1328, 1151, 1083, 833, 553. HRMS m/z (ESI) calcd for C21H14ClFIO3S (M + H)+ 526.9375, found 526.9378. (E)-1-(2-Bromophenyl)-3-(4-fluorophenyl)-3-iodo-2(phenylsulfonyl)prop-2-en-1-one (3y). Yellow solid; mp 134− 135 °C; yield 76%. 1H NMR (300 MHz, CDCl3): δ 8.21 (d, J = 7.7 Hz, 1H), 7.80 (d, J = 7.8 Hz, 1H), 7.60−7.54 (m, 4H), 7.50−7.45 (m, 1H), 7.42−7.37 (m, 2H), 7.14−7.09 (m, 2H), 6.97 (t, J = 8.6 Hz, 2H). 13C NMR (125 MHz, CDCl3): δ 189.3, 163.3 (d, J = 250.0 Hz), 150.2, 140.7, 136.2 (d, J = 2.5 Hz), 135.9, 134.5, 134.2, 133.7, 129.9 (d, J = 8.8 Hz), 129.1, 128.6, 128.0, 123.9, 115.3 (d, J = 22.1 Hz), 113.8. IR (KBr, ν, cm−1): 3109, 3062, 1683, 1600, 1502, 1327, 1230, 1155, 837, 688, 557. HRMS m/z (ESI) calcd for C21H14BrFIO3S (M + H)+ 570.8870, found 570.8868. (E)-3-(4-Chlorophenyl)-3-iodo-2-(phenylsulfonyl)-1-(2tolyl)prop-2-en-1-one (3z). Yellow solid; mp 171−172 °C; yield 79%. 1H NMR (300 MHz, CDCl3): δ 8.18 (d, J = 7.1 Hz,
2H), 7.58−7.50 (m, 4H), 7.46−7.42 (m, 1H), 7.40−7.35 (m, 3H), 7.23 (d, J = 8.6 Hz, 2H), 7.06 (d, J = 8.4 Hz, 2H), 2.72 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 191.9, 151.5, 142.7, 140.8, 138.8, 136.1, 134.2, 134.1, 133.2, 133.0, 132.9, 129.3, 129.2, 128.7, 128.6, 126.8, 112.3, 22.5. IR (KBr, ν, cm−1): 3066, 3014, 1674, 1602, 1483, 1323, 1153, 1082, 827, 785, 555. HRMS m/z (ESI) calcd for C22H17ClIO3S (M + H)+ 522.9626, found 522.9622. Typical Experimental Procedure for the Synthesis of Functionalized Tetrasubstituted Allylic Alcohols 5. Under argon atmosphere, a Schlenk flask equipped with a condenser was charged with 0.25 mmol (75 mg) of 1-(2bromophenyl)-3-(4-tolyl)prop-2-yn-1-ol (4a), 0.5 mmol (82 mg) of sodium benzenesulfinate (2a), 0.375 mmol (95 mg) of I2, and 3 mL of 1,2-dichloroethane/H2O (v/v 2/1). The reaction mixture was stirred at reflux until the complete consumption of 4a (monitored by TLC). The reaction was then quenched with saturated NH4Cl and extracted with ethyl acetate (3 × 15 mL). The organic layer was washed with saturated Na2S2O3 and dried over anhydrous Na2SO4. After filtration and removal of the solvent in vacuo, the crude product was purified by flash column chromatography on silica gel (silica gel, petroleum ether/ethyl acetate = 15/1) to give product 5a. (E)-1-(2-Bromophenyl)-3-iodo-2-(phenylsulfonyl)-3-(ptolyl)prop-2-en-1-ol (5a). Yellow solid; mp 105−106 °C; yield 95%. 1H NMR (500 MHz, CDCl3): δ 7.88 (d, J = 7.6 Hz, 1H), 7.50−7.44 (m, 2H), 7.42−7.39 (m, 1H), 7.23−7.17 (m, 6H), 6.98 (br, 3H), 6.19 (d, J = 11.6 Hz, 1H), 4.50 (d, J = 11.6 Hz, 1H), 2.33 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 145.5, 140.5, 140.0, 139.4, 138.9, 133.0, 132.9, 129.6, 129.5, 128.3, 127.5, 127.4, 124.7, 123.5, 83.0, 21.4. IR (KBr, ν, cm−1): 3616, 3090, 2852, 2893, 1602, 1571, 1500, 1465, 1253, 820, 743; HRMS m/z (ESI) calcd for C22H17BrIO2S (M − OH)+ 550.9177, found 550.9184. (E)-1-(2-Bromophenyl)-3-iodo-3-(p-tolyl)-2-tosylprop-2en-1-ol (5b). White solid; mp 153−154 °C; yield 93%. 1H NMR (300 MHz, CDCl3): δ 7.87 (d, J = 7.7 Hz, 1H), 7.52− 7.43 (m, 2H), 7.22 (t, J = 7.4 Hz, 1H), 7.06−7.05 (m, 3H), 6.99−6.96 (m, 5H), 6.18 (d, J = 11.5 Hz, 1H), 4.53 (d, J = 11.6 Hz, 1H), 2.34 (s, 6H). 13C NMR (125 MHz, CDCl3): δ 146.2, 144.3, 140.6, 139.7, 139.4, 138.0, 133.4, 130.0, 129.9, 129.3, 128.7, 128.1, 127.8, 124.7, 124.6, 124.0, 83.4, 22.0, 21.8. IR (KBr, ν, cm−1): 3622, 2918, 1662, 1595, 1577, 1501, 816, 770. HRMS m/z (ESI) calcd for C23H19BrIO2S (M − OH)+ 564.9334, found 564.9342. (E)-1-(2-Bromophenyl)-3-iodo-2-(methylsulfonyl)-3-(ptolyl)prop-2-en-1-ol (5c). White solid; mp 177−178 °C; yield: 58%. 1H NMR (300 MHz, CDCl3): δ 7.76 (d, J = 7.7 Hz, 1H), 7.63 (d, J = 7.7 Hz, 1H), 7.44 (t, J = 7.4 Hz, 1H), 7.22 (t, J = 10.22 Hz 5H), 6.15 (d, J = 11.8 Hz, 1H), 4.18 (d, J = 11.5 Hz, 1H), 2.44 (s, 3H), 2.37 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 143.9, 140.8, 139.9, 138.8, 133.0, 130.0, 129.6, 128.9, 127.7, 126.4, 123.5, 82.4, 45.6, 21.5. IR (KBr, ν, cm−1): 3566, 2928, 1581, 1502, 1463, 825, 777. HRMS m/z (ESI) calcd for C17H15BrIO2S (M − OH)+ 488.9021, found 488.9025. (E)-1-(2-Bromophenyl)-2-((4-chlorophenyl)sulfonyl)-3iodo-3-(p-tolyl)prop-2-en-1-ol (5d). Yellow solid; mp 134− 135 °C; yield: 76%. 1H NMR (500 MHz, CDCl3): δ 7.86 (d, J = 7.6 Hz, 1H), 7.51−7.50 (m, 1H), 7.46 (t, J = 7.7 Hz, 1H), 7.25−7.21 (m, 1H), 7.15−7.09 (m, 5H), 7.01 (br, 2H), 6.79 (br, 1H), 6.19 (d, J = 11.2 Hz, 1H), 4.39 (d, J = 11.5 Hz, 1H), 2.35 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 145.3, 140.0, 18009
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015
ACS Omega
Article
cm−1): 3495, 2945, 1598, 1577, 1512, 1444, 833, 734, 688. HRMS m/z (ESI) calcd for C22H20IO3S (M + H)+ 491.0172, found 491.0179. (E)-1-(4-Fluorophenyl)-3-iodo-3-phenyl-2(phenylsulfonyl)prop-2-en-1-ol (5k). White solid; mp 173− 174 °C; yield 87%. 1H NMR (300 MHz, CDCl3): δ 7.70−7.61 (m, 2H), 7.42 (t, J = 7.3 Hz, 1H), 7.21−7.14 (m, 7H), 7.09− 7.07 (m, 3H), 6.78 (br, 1H), 6.34 (d, J = 10.0 Hz, 1H), 4.72 (d, J = 11.5 Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 162.5 (d, J = 244.8 Hz), 149.1, 141.5, 140.5, 135.7 (d, J = 2.9 Hz), 133.1, 129.0, 128.5, 127.8, 127.3, 127.2, 127.1 (d, J = 8.2 Hz), 120.0, 115.6 (d, J = 21.5 Hz), 82.9. IR (KBr, ν, cm−1): 3473, 3047, 1602, 1581, 1448, 839, 781, 732, 680. HRMS m/z (ESI) calcd for C21H15FIO2S (M − OH)+ 476.9821, found 476.9828. (E)-1-(4-Chlorophenyl)-3-iodo-3-phenyl-2(phenylsulfonyl)prop-2-en-1-ol (5l). White solid; mp 155− 156 °C; yield 74%. 1H NMR (300 MHz, CDCl3): δ 7.60 (d, J = 8.3 Hz, 2H), 7.42 (t, J = 8.7 Hz, 3H), 7.18 (t, J = 7.7 Hz, 5H), 7.07 (d, J = 7.9 Hz, 3H), 6.77 (br, 1H), 6.33 (d, J = 9.9 Hz, 1H), 4.71 (d, J = 12.0 Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 149.0, 141.4, 140.5, 138.5, 133.9, 133.1, 129.0, 128.9, 128.5, 127.8, 127.3, 126.8, 120.2, 82.9. IR (KBr, ν, cm−1): 3645, 3057, 1575, 1489, 1442, 841, 734, 696. HRMS m/z (ESI) calcd for C21H15ClIO2S (M − OH)+ 492.9526, found 492.9524. (E)-1-(4-Bromophenyl)-3-iodo-3-phenyl-2(phenylsulfonyl)prop-2-en-1-ol (5m). White solid; mp 174− 175 °C; yield 66%. 1H NMR (300 MHz, CDCl3): δ 7.56 (q, J = 9.6 Hz, 3H), 7.42 (t, J = 7.4 Hz, 1H), 7.25−7.10 (m, 5H), 7.07 (d, J = 7.7 Hz, 3H), 6.77 (br, 2H), 6.31 (d, J = 12.0 Hz, 1H), 4.70 (d, J = 12.0 Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 148.9, 141.4, 140.4, 139.1, 133.1, 131.8, 129.1, 128.5, 127.8, 127.3, 127.1, 122.1, 120.3, 82.9. IR (KBr, ν, cm−1): 3543, 3055, 1685, 1610, 1575, 1512, 1463, 840, 734, 688. HRMS m/ z (ESI) calcd for C21H15BrIO2S (M − OH)+ 536.9021, found 536.9025. (E)-1-Iodo-1-phenyl-2-(phenylsulfonyl)hex-1-en-3-ol (5n). White solid; mp 106−107 °C; yield 89%. 1H NMR (300 MHz, CDCl3): δ 7.41 (t, J = 7.0 Hz, 1H), 7.28−7.17 (m, 4H), 7.14− 7.06 (m, 2H), 7.02−6.91 (m, 2H), 6.59 (br, 1H), 5.10−5.01 (m, 1H), 3.93 (d, J = 11.9 Hz, 1H), 2.27−2.06 (m, 2H), 1.77− 1.61 (m, 2H), 1.09 (t, J = 7.3 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 149.6, 141.7, 141.0, 132.8, 128.7, 128.5, 127.6, 127.1, 116.8, 82.9, 38.7, 19.5, 14.0. IR (KBr, ν, cm−1): 3614, 3064, 2867, 1602, 1570, 1481, 734, 684. HRMS m/z (ESI) calcd for C18H18IO2S (M − OH)+ 425.0072, found 425.0080. (E)-3-Iodo-1-(4-methoxyphenyl)-3-phenyl-2(phenylsulfonyl)prop-2-en-1-ol (5o). Yellow solid; mp 148− 149 °C; yield 81%. 1H NMR (300 MHz, CDCl3): δ 7.59 (d, J = 8.3 Hz, 2H), 7.41 (t, J = 6.9 Hz, 1H), 7.24−7.14 (m, 5H), 7.13−7.06 (m, 3H), 7.01 (d, J = 8.4 Hz, 2H), 6.79 (br, 1H), 6.33 (d, J = 11.9 Hz, 1H), 4.67, (d, J = 12.0 Hz, 1H), 3.86 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 159.4, 149.3, 141.6, 140.7, 133.0, 131.9, 128.9, 128.5, 127.7, 127.4, 126.6, 119.4, 114.1, 83.1, 55.4. IR (KBr, ν, cm−1): 3651, 3105, 1601, 1577, 1506, 1440, 737, 691. HRMS m/z (ESI) calcd for C22H18IO3S (M − OH)+ 489.0021, found 489.0024. (E)-3-Iodo-1,3-bis(4-methoxyphenyl)-2-(phenylsulfonyl)prop-2-en-1-ol (5p). White solid; mp 100−101 °C; yield 72%. 1 H NMR (300 MHz, CDCl3): δ 7.58 (d, J = 7.8 Hz, 2H), 7.40 (t, J = 6.7 Hz, 1H), 7.19−7.11 (m, 4H), 7.01−6.80 (m, 4H), 6.62 (br, 2H), 6.30 (d, J = 11.5 Hz, 1H), 4.66 (d, J = 11.9 Hz, 1H), 3.87 (s, 3H), 3.80 (s, 3H). 13C NMR (75 MHz, CDCl3):
139.7, 139.6, 138.8, 138.7, 133.0, 129.7, 129.4, 129.0, 128.6, 127.4, 125.1, 123.4, 82.9, 21.4. IR (KBr, ν, cm−1): 3564, 2856, 1672, 1529, 898, 816, 701. HRMS m/z (ESI) calcd for C22H16BrClIO2S (M − OH)+ 584.8788, found 584.8786. (E)-3-Iodo-1-phenyl-2-(phenylsulfonyl)-3-(p-tolyl)prop-2en-1-ol (5e). White solid; mp 163−164 °C; yield 70%. 1H NMR (300 MHz, CDCl3): δ 7.66 (d, J = 7.3 Hz, 2H), 7.49− 7.38 (m, 4H), 7.15 (t, J = 7.7 Hz, 2H), 7.06−7.04 (m, 2H), 6.93 (br, 4H), 6.38 (d, J = 8.9 Hz, 1H), 4.69 (d, J = 10.8 Hz, 1H), 2.33 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 149.2, 140.7, 140.0, 139.2, 138.9, 132.9, 128.7, 128.3, 128.2, 128.0, 127.9, 127.4, 125.3, 120.4, 83.3, 21.3. IR (KBr, ν, cm−1): 3628, 2914, 1639, 1537, 1462, 816. HRMS m/z (ESI) calcd for C22H18IO2S (M − OH)+ 473.0072, found 473.0074. (E)-3-Iodo-2-(phenylsulfonyl)-1,3-(di-p-tolyl)prop-2-en-1ol (5f). White solid; mp 171−172 °C; yield 78%. 1H NMR (300 MHz, CDCl3): δ 7.54 (d, J = 7.8 Hz, 2H), 7.40 (t, J = 7.2 Hz, 1H), 7.28 (s, 1H), 7.18−7.08 (m, 5H), 6.92 (br, 4H), 6.34 (d, J = 11.9 Hz, 1H), 4.64 (d, J = 12.0 Hz, 1H), 2.40 (s, 3H), 2.33 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 149.2, 140.8, 139.2, 138.9, 137.7, 136.9, 132.8, 129.7, 129.4, 128.3, 127.9, 127.4, 125.2, 120.0, 83.3, 21.4, 21.2. IR (KBr, ν, cm−1): 3535, 2908, 2910, 1527, 1444, 846, 806. HRMS m/z (ESI) calcd for C23H20IO2S (M − OH)+ 487.0229, found 487.0236. (E)-1-(4-Chlorophenyl)-3-iodo-2-(phenylsulfonyl)-3-(ptolyl)prop-2-en-1-ol (5g). White solid; mp 145−146 °C; yield 96%. 1H NMR (300 MHz, CDCl3): δ 7.59 (d, J = 8.4 Hz, 2H), 7.43 (d, J = 8.2 Hz, 3H), 7.21−7.08 (m, 4H), 6.92 (br, 4H), 6.32 (d, J = 11.6 Hz, 1H), 4.69 (d, J = 11.9 Hz, 1H), 2.33 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 148.9, 140.7, 139.5, 138.8, 138.7, 134.0, 133.2, 129.0, 128.5, 128.0, 127.5, 126.9, 120.9, 83.0, 21.5. IR (KBr, ν, cm−1): 3568, 3028, 3030, 1517, 1446, 1083, 848. HRMS m/z (ESI) calcd for C22H17ClIO2S (M − OH)+ 506.9682, found 506.9680. (E)-3-Iodo-2-(phenylsulfonyl)-1-(o-tolyl)-3-(p-tolyl)prop-2en-1-ol (5h). Yellow solid; mp 143−144 °C; yield 83%. 1H NMR (500 MHz, CDCl3): δ 7.76 (d, J = 7.6 Hz, 1H), 7.45 (t, J = 7.4 Hz, 1H), 7.34−7.29 (m, 4H), 7.26−7.23 (m, 3H), 7.18−7.16 (m, 1H), 7.02 (br, 3H), 6.20 (d, J = 11.6 Hz, 1H), 4.43 (d, J = 11.8 Hz, 1H), 2.47 (s, 3H), 2.34 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 147.2, 141.0, 139.6, 139.2, 137.9, 137.0, 133.0, 130.7, 128.4, 128.3, 127.6, 127.4, 126.6, 126.1, 121.7, 82.1, 21.4, 20.2. IR (KBr, ν, cm−1): 3547, 2922, 1635, 1622, 1550, 1485, 815, 746. HRMS m/z (ESI) calcd for C23H20IO2S (M − OH)+ 487.0229, found 487.0235. (E)-3-Iodo-1,3-diphenyl-2-(phenylsulfonyl)prop-2-en-1-ol (5i). White solid; mp 126−127 °C; yield 95%. 1H NMR (500 MHz, CDCl3): δ 7.67 (d, J = 8.1 Hz, 2H), 7.48 (t, J = 7.4 Hz, 2H), 7.40 (t, J = 7.3 Hz, 2H), 7.19−7.14 (m, 4H), 7.10 (br, 1H), 7.04−7.02 (m, 3H), 6.84 (br, 1H), 6.40 (d, J = 12.0 Hz, 1H), 4.71 (d, J = 12.0 Hz 1H). 13C NMR (75 MHz, CDCl3): δ 149.4, 141.6, 140.6, 139.9, 133.0, 128.9, 128.7, 128.4, 128.0, 127.7, 127.4, 125.3, 119.8, 83.3. IR (KBr, ν, cm−1): 3500, 3057, 1707, 1583, 1487, 748, 684. HRMS m/z (ESI) calcd for C21H16IO2S (M − OH)+ 458.9916, found 458.9921. (E)-3-Iodo-3-phenyl-2-(phenylsulfonyl)-1-(p-tolyl)prop-2en-1-ol (5j). White solid; mp 169−170 °C; yield 82%. 1H NMR (300 MHz, CDCl3): δ 7.55 (d, J = 6.7 Hz, 2H), 7.39 (d, J = 6.9 Hz, 1H), 7.29−7.25 (m, 2H), 7.19−7.14 (m, 4H), 7.13−7.04 (m, 4H), 6.79 (br, 1H), 6.35 (d, J = 11.1 Hz, 1H), 4.65 (d, J = 11.5 Hz, 1H), 2.41 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 149.8, 142.0, 141.1, 138.1, 137.3, 133.3, 129.8, 129.3, 128.8, 128.1, 127.8, 125.6, 119.8, 83.7, 21.6. IR (KBr, ν, 18010
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015
ACS Omega
Article
δ 160.0, 159.3, 149.1, 140.9, 134.1, 132.9, 132.0, 129.7, 128.4, 127.3, 126.6, 119.9, 114.1, 113.1, 83.2, 55.4, 55.3. IR (KBr, ν, cm−1): 3622, 3003, 2977, 2847, 1674, 1587, 837, 761. HRMS m/z (ESI) calcd for C23H20IO4S (M − OH)+ 519.0127, found 519.0135. (E)-3-Iodo-3-(4-methoxyphenyl)-2-(phenylsulfonyl)-1-(ptolyl)prop-2-en-1-ol (5q). White solid; mp 131−132 °C; yield 94%. 1H NMR (300 MHz, CDCl3): δ 7.55 (d, J = 7.9 Hz, 2H), 7.40 (t, J = 7.3 Hz, 1H), 7.28 (d, J = 7.9 Hz, 2H), 7.19 (t, J = 7.7 Hz, 2H), 7.12 (d, J = 7.9 Hz, 2H), 6.95 (br, 2H), 6.63 (s, 2H), 6.33 (d, J = 12.1 Hz, 1H), 4.65 (d, J = 12.1 Hz, 1H), 3.81 (s, 3H), 2.41 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 160.4, 149.7, 141.2, 138.0, 137.4, 134.5, 133.3, 130.2, 129.8, 128.7, 127.7, 125.6, 120.4, 113.5, 83.8, 55.8, 21.6. IR (KBr, ν, cm−1): 3601, 2836, 2900, 1641, 1500, 1481, 833, 733, 685. HRMS m/ z (ESI) calcd for C23H20IO3S (M − OH)+ 503.0178, found 503.0170. (E)-3-Iodo-3-(4-methoxyphenyl)-1-phenyl-2(phenylsulfonyl)prop-2-en-1-ol (5r). White solid; mp 127− 128 °C; yield 76%. 1H NMR (500 MHz, CDCl3): δ 7.67 (d, J = 7.9 Hz, 2H), 7.48 (t, J = 7.6 Hz, 2H), 7.40 (q, J = 7.1 Hz, 2H), 7.18 (t, J = 7.9 Hz, 2H), 7.08 (d, J = 7.6 Hz, 2H), 6.92 (br, 2H), 6.64 (s, 2H), 6.38 (d, J = 12.1 Hz, 1H), 4.70 (d, J = 12.1 Hz, 1H), 3.81 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 160.4, 149.7, 141.2, 140.4, 134.4, 133.3, 130.2, 129.1, 128.7, 128.3, 127.7, 125.6, 120.7, 113.5, 83.8, 55.8. IR (KBr, ν, cm−1): 3626, 2895, 2897, 1602, 1578, 1474, 837, 746, 685. HRMS m/ z (ESI) calcd for C22H18IO3S (M − OH)+ 489.0021, found 489.0023. (E)-1-(4-Chlorophenyl)-3-iodo-3-(4-methoxyphenyl)-2(phenylsulfonyl)prop-2-en-1-ol (5s). White solid; mp 170− 171 °C; yield 53%. 1H NMR (300 MHz, CDCl3): δ 7.59 (d, J = 7.7 Hz, 2H), 7.43 (d, J = 7.9 Hz, 3H), 7.20 (t, J = 7.2 Hz, 2H), 7.13−7.10 (m, 2H), 6.90 (br, 2H), 6.63 (s, 2H), 6.31 (d, J = 10.8 Hz, 1H), 4.69 (d, J = 11.3 Hz, 1H) 3.81 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 160.1, 148.8, 140.6, 138.6, 133.8, 133.0, 129.7, 128.8, 128.4, 127.2, 126.8, 120.8, 113.1, 83.0, 55.4. IR (KBr, ν, cm−1): 3566, 3050, 1668, 1585, 1475, 829, 762, 684. HRMS m/z (ESI) calcd for C22H17IClO3S (M − OH)+ 522.9632, found 522.9640. (E)-1-(4-Bromophenyl)-3-iodo-3-(4-methoxyphenyl)-2(phenylsulfonyl)prop-2-en-1-ol (5t). White solid; mp 176− 177 °C; yield 52%. 1H NMR (300 MHz, CDCl3): δ 7.56 (q, J = 8.5 Hz, 4H), 7.42 (t, J = 7.3 Hz, 1H), 7.21 (t, J = 7.5 Hz, 2H), 7.15−7.08 (m, 2H), 6.91 (br, 2H), 6.63 (d, J = 6.4 Hz, 2H), 6.29 (d, J = 9.7 Hz, 1H), 4.69 (d, J = 11.2 Hz, 1H), 3.81, (s, 3H). 13C NMR (75 MHz, CDCl3): δ 160.1, 148.8, 140.6, 139.2, 133.0, 131.8, 129.7, 128.4, 127.2, 127.1, 122.0, 120.8, 113.2, 83.0, 55.4. IR (KBr, ν, cm−1): 3487, 3051, 2960, 2827, 1589,1502, 1527, 1467, 829, 731, 681. HRMS m/z (ESI) calcd for C22H17IBrO3S (M − OH)+ 566.9126, found 566.9128. (E)-3-Iodo-3-(4-methoxyphenyl)-2-(phenylsulfonyl)-1-(otolyl)prop-2-en-1-ol (5u). Yellow solid; mp 116−117 °C; yield 80%. 1H NMR (300 MHz, CDCl3): δ 7.77 (d, J = 7.3 Hz, 1H), 7.33−7.30 (m, 3H), 7.29−7.24 (m, 3H), 7.20−7.16 (m, 2H), 6.95 (br, 2H), 6.66 (s, 2H), 6.20 (d, J = 11.5 Hz, 1H), 4.46 (d, J = 11.8 Hz, 1H), 3.81, (s, 3H), 2,48 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 160.0, 147.4, 141.1, 137.9, 137.0, 134.7, 133.0, 130.8, 129.4, 128.5, 128.3, 127.5, 126.8, 126.1, 121.6, 113.1, 82.3, 55.4, 20.2. IR (KBr, ν, cm−1): 3626, 2910, 2837, 1676, 1537, 1475, 1423, 840, 773, 750, 686. HRMS m/z (ESI) calcd for C23H20IO3S (M − OH)+ 503.0178, found 503.0173.
(E)-1-(2-Chlorophenyl)-3-iodo-3-(4-methoxyphenyl)-2(phenylsulfonyl)prop-2-en-1-ol (5v). Yellow solid; mp 138− 139 °C; yield 91%. 1H NMR (300 MHz, CDCl3): δ 7.88 (d, J = 7.6 Hz, 1H), 7.44−7.31 (m, 5H), 7.21−7.12 (m, 5H), 6.62 (br, 2H), 6.28 (d, J = 11.6 Hz, 1H), 4.60 (d, J = 11.7 Hz, 1H), 3.79, (s, 3H). 13C NMR (75 MHz, CDCl3): δ 160.2, 145.5, 140.5, 137.3, 134.9, 133.2, 132.9, 129.7, 129.4, 128.9, 128.4, 127.8, 127.3, 126.8, 123.6, 113.8, 81.7, 55.4. IR (KBr, ν, cm−1): 3500, 3065, 2962, 2914, 1600, 1577, 1500, 1460, 839, 758, 685, 650. HRMS m/z (ESI) calcd for C22H17ClIO3S (M − OH)+ 522.9632, found 522.9639. (E)-1-(4-Chlorophenyl)-3-iodo-3-(4-methoxyphenyl)-2-tosylprop-2-en-1-ol (5w). White solid; mp 160−161 °C; yield 65%. 1H NMR (300 MHz, CDCl3): δ 7.58 (d, J = 8.3 Hz, 2H), 7.42 (d, J = 8.3 Hz, 2H), 7.08−6.92 (m, 6H), 6.65 (d, J = 7.6 Hz, 2H), 6.30 (d, J = 12.0 Hz, 1H), 4.71 (d, J = 11.9 Hz, 1H), 3.81 (s, 3H), 2.34 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 160.1, 149.0, 144.1, 138.7, 137.7, 134.0, 133.8, 129.7, 129.0, 128.8, 127.4, 126.8, 120.5, 113.1, 83.0, 55.4, 21.6. IR (KBr, ν, cm−1): 3630, 3058, 3048, 3009, 1604, 1504, 831, 760, 694. HRMS m/z (ESI) calcd for C23H19ClIO3S (M − OH)+ 536.9788, found 536.5783. (E)-1-(4-Chlorophenyl)-3-iodo-3-(4-methoxyphenyl)-2(methylsulfonyl)prop-2-en-1-ol (5x). Yellow solid; mp 191− 192 °C; yield 77%. 1H NMR (300 MHz, CDCl3): δ 7.52 (d, J = 8.2 Hz, 2H), 7.39 (t, J = 9.0 Hz, 4H), 6.93 (d, J = 8.6 Hz, 2H), 6.22 (d, J = 8.4 Hz, 1H), 4.36 (d, J = 10.4 Hz, 1H), 3.84 (s, 3H), 2.53 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 160.6, 147.2, 138.3, 134.2, 134.0, 129.4, 128.9, 126.8, 113.7, 82.8, 55.4, 45.8. IR (KBr, ν, cm−1): 3585, 2891, 2839, 1651, 1607, 1508, 837, 775, 669. HRMS m/z (ESI) calcd for C17H15ClIO3S (M − OH)+ 460.9475, found 460.9469. (E)-1-(4-Chlorophenyl)-3-(4-fluorphenyl)-3-iodo-2(phenylsulfonyl)prop-2-en-1-ol (5y). White solid; mp 178− 179 °C; yield 61%. 1H NMR (300 MHz, CDCl3): δ 7.59 (d, J = 8.5 Hz, 2H), 7.46 (t, J = 8.7 Hz, 3H), 7.25 (t, J = 3.8 Hz, 3H), 7.16−7.12 (m, 2H), 6.80 (br, 3H), 6.32 (d, J = 10.1 Hz, 1H), 4.67 (d, J = 11.3 Hz, 1 H). 13C NMR (125 MHz, CDCl3): δ 163.0 (d, J = 250.0 Hz), 150.2, 140.9, 138.7, 137.9, 134.4, 133.7, 130.5 (d, J = 5.3 Hz), 129.3, 129.0, 127.6, 127.1, 118.9, 115.3 (d, J = 21.6 Hz), 83.18. IR (KBr, ν, cm−1): 2643, 3060, 2804, 1602, 1501, 1306, 806, 733, 687. HRMS m/z (ESI) calcd for C21H14ClFIO2S (M − OH)+ 510.9432, found 510.9426. (E)-3-(4-Fluorophenyl)-3-iodo-2-(phenylsulfonyl)-1-(otolyl)prop-2-en-1-ol (5z). Yellow solid; mp 129−130 °C; yield 87%. 1H NMR (500 MHz, CDCl3): δ 7.75 (d, J = 7.5 Hz, 1H), 7.49 (t, J = 7.3 Hz, 1H), 7.36−7.33 (m, 3H), 7.32−7.28 (m, 4H), 7.19 (d, J = 7.3 Hz, 1H), 6.85 (br, 3H), 6.20 (d, J = 11.8 Hz, 1H), 4.41 (d, J = 11.8 Hz, 1H), 2.49 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 162.60 (d, J = 249.38), 148.39, 140.91, 138.30, 137.37 (d, J = 39.0 Hz), 133.28, 130.83, 129.72, 128.67, 128.52, 127.50, 126.47 (d, J = 47.78 Hz), 119.57, 114.88 (d, J = 22.1 Hz), 20.15. IR (KBr, ν, cm−1): 3626, 3014, 1649, 1589, 1527, 1477, 836, 781, 681. HRMS m/z (ESI) calcd for C22H17FIO2S (M − OH)+ 490.9978, found 490.9985. Typical Experimental Procedure for the Synthesis of Funtionalized Conjugated Enynes 7. Under argon atmosphere, a Schlenk flask equipped with a condenser was charged with 0.25 mmol (51 mg) of 1,4-diphenylbuta-1,3diyne (6a), 0.5 mmol (82 mg) of sodium benzenesulfinate (2a), 0.375 mmol (95 mg) of I2, and 3 mL of 1,2dichloroethane/H2O (v/v 2/1). The reaction mixture was 18011
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015
ACS Omega
Article
(ESI) calcd for C19H18IO2S (M + H)+ 437.0067, found 437.0073. (E)-2-Iodo-1,4-di(p-fluorophenyl)-1-methylsulfonylbut-1en-3-yne (7g). Yellow solid; mp 98−99 °C; yield 48%. 1H NMR (300 MHz, CDCl3): δ 7.59−7.55 (m, 2H), 7.34−7.32 (m, 2H), 7.19−7.07 (m, 4H), 3.02 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 164.2 (d, J = 251.7 Hz), 163.9 (d, J = 249.5 Hz), 151.5, 134.7 (d, J = 8.75 Hz), 133.8 (d, J = 3.4 Hz), 132.2 (d, J = 8.5 Hz), 117.7 (d, J = 3.1 Hz), 116.5 (d, J = 22.1 Hz), 107.3, 89.8, 89.0, 42.6. IR (KBr, ν, cm−1): 3063, 2198, 1597, 1489, 1325, 1149, 840, 572. HRMS m/z (ESI) calcd for C17H12F2IO2S (M + H)+ 444.9565, found 444.9572. (E)-2-Iodo-1,4-di(p-fluorophenyl)-1-(phenylsulfonyl)but1-en-3-yne (7h). Yellow solid; mp 117−118 °C; yield 57%. 1H NMR (300 MHz, CDCl3): δ 7.73 (d, J = 7.4 Hz, 2H), 7.64− 7.58 (m, 3H), 7.44 (t, J = 7.8 Hz, 2H), 7.12 (t, J = 8.7 Hz, 2H), 7.02 (d, J = 6.9 Hz, 4H). 13C NMR (125 MHz, CDCl3): δ 164.9 (d, J = 251.5 Hz), 162.9 (d, J = 248.9 Hz), 151.5, 139.7, 134.6 (d, J = 8.7 Hz), 134.2, 134.1 (d, J = 3.4 Hz), 132.5 (d, J = 8.5 Hz), 129.4, 128.8, 118.1 (d, J = 7.5 Hz), 116.5 (d, J = 22 Hz), 116.0 (d, J = 22.1 Hz), 107.0, 90.2, 89.4. IR (KBr, ν, cm−1): 3070, 2189, 1575, 1313, 1153, 842, 582. HRMS m/z (ESI) calcd for C22H14F2IO2S (M + H)+ 506.9722, found 506.9725. (E)-2-Iodo-1,4-di(p-fluorophenyl)-1-tosylbut-1-en-3-yne (7i). Yellow solid; mp 124−125 °C; yield 65%. 1H NMR (300 MHz, CDCl3): δ 7.63−7.59 (m, 4H), 7.23 (d, J = 8.1 Hz, 2H), 7.12 (t, J = 8.7 Hz, 2H), 7.03 (d, J = 6.9 Hz, 4H), 2.40 (s, 3H). 13 C NMR (125 MHz, CDCl3): δ 164.0 (d, J = 250.0 Hz), 163.7 (d, J = 248.9 Hz), 151.9, 145.4, 136.8, 134.6 (d, J = 8.4 Hz), 132.5 (d, J = 6.0 Hz), 130.0, 128.9, 118.1 (d, J = 3.1 Hz), 116.5 (d, J = 25 Hz), 116.0 (d, J = 19.4 Hz), 106.7, 89.8, 89.4, 22.1. IR (KBr, ν, cm−1): 2918, 2174, 1575, 1149, 817, 584. HRMS m/z (ESI) calcd for C 23H16F2 IO 2S (M + H) + 520.9878, found 520.9881. (E)-2-Iodo-1,4-di(p-methoxyphenyl)-1-tosylbut-1-en-3yne (7j). Yellow solid; mp 143−144 °C; yield 65%. 1H NMR (300 MHz, CDCl3): δ 7.64 (d, J = 8.2 Hz, 2H), 7.55 (d, J = 8.7 Hz, 2H), 7.22 (d, J = 8.1 Hz, 2H), 6.99 (d, J = 8.7 Hz, 2H), 6.93 (d, J = 8.1 Hz, 2H), 6.86 (d, J = 8.8 Hz, 2H), 3.85 (s, 3H), 3.83 (s, 3H), 2.39 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 161.5, 160.8, 151.5, 144.9, 137.4, 134.2, 132.0, 130.8, 129.9, 128.9, 114.7, 114.2, 114.0, 108.2, 90.4, 89.4, 55.8, 55.7, 22.1. IR (KBr, ν, cm−1): 2964, 2175, 1570, 1496, 1249, 1149, 831, 569. HRMS m/z (ESI) calcd for C25H22IO4S (M + H)+ 545.0278, found 545.0281. (E)-2-Iodo-1,4-di(p-chlorophenyl)-1-tosylbut-1-en-3-yne (7k). Yellow solid; mp 145−146 °C; yield 61%. 1H NMR (300 MHz, CDCl3): δ 7.60 (d, J = 8.2 Hz, 2H), 7.54 (d, J = 8.4 Hz, 2H), 7.40 (d, J = 8.4 Hz, 2H), 7.32 (d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.1 Hz, 2H), 6.98 (d, J = 8.4 Hz, 2H), 2.40 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 152.2, 145.5, 136.9, 136.7, 136.6, 136.3, 133.6, 131.8, 130.1, 129.4, 129.1, 128.9, 120.4, 106.6, 90.3, 89.4, 22.1. IR (KBr, ν, cm−1): 3057, 2194, 1568, 1494, 1228, 1153, 840, 584. HRMS m/z (ESI) calcd for C23H16Cl2IO2S (M + H)+ 552.9287, found 552.9295. Typical Experimental Procedure for Suzuki Coupling Reaction of Vinyl Iodides (3a, 5e, and 7b) with pTolylboronic Acid. Under an argon atmosphere, 0.5 mmol (244 mg) of (E)-3-iodo-3-phenyl-2-(phenylsulfonyl)-1-(4tolyl)- prop-2-en-1-one (3a) was added to the mixture of 0.6 mmol (82 mg) of p-tolylboronic acid, 0.05 mmol (35 mg) of Pd(PPh3)2Cl2, and 0.6 mmol (83 mg) of K2CO3 in 3 mL of
stirred at reflux until the complete consumption of 6a (monitored by TLC). The reaction was then quenched with saturated NH4Cl and extracted with ethyl acetate (3 × 15 mL). The organic layer was washed with saturated Na2S2O3 and dried over anhydrous Na2SO4. After filtration and removal of the solvent in vacuo, the crude product was purified by flash column chromatography on silica gel (silica gel, petroleum ether/ethyl acetate = 20/1) to give product 7a. (E)-2-Iodo-1,4-diphenyl-1-phenylsulfonylbut-1-en-3-yne (7a). Yellow solid; mp 95−96 °C; yield 62%. 1H NMR (300 MHz, CDCl3): δ 7.76 (d, J = 7.6 Hz, 2H), 7.62−7.56 (m, 3H), 7.45−7.41 (m, 5H), 7.35 (d, J = 7.6 Hz, 3H), 7.05 (d, J = 6.1 Hz, 2H). 13C NMR (125 MHz, CDCl3): δ 152.6, 140.0, 138.4, 134.1, 132.4, 130.5, 130.3, 130.0, 129.5, 129.3, 129.0, 128.7, 122.0, 107.8, 89.9, 89.7. IR (KBr, ν, cm−1): 3076, 2181, 1573, 1496, 1313, 1153, 835, 576. HRMS m/z (ESI) calcd for C22H16IO2S (M + H)+ 470.9910, found 470.9917. (E)-2-Iodo-1,4-diphenyl-1-tosylbut-1-en-3-yne (7b). Yellow solid; mp 121−122 °C; yield 71%. 1H NMR (300 MHz, CDCl3): δ 7.65−7.60 (m, 4H), 7.43−7.32 (m, 6H), 7.22 (d, J = 7.0 Hz, 2H), 7.06 (d, J = 7.5 Hz, 2H), 2.39 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 153.0, 145.2, 138.5, 137.1, 132.4, 130.5, 130.3, 129.9, 129.6, 129.0, 128.9, 128.7, 122.1, 107.6, 89.7, 89.5, 22.1. IR (KBr, ν, cm−1): 3059, 2194, 1597, 1332, 1149, 569. HRMS m/z (ESI) calcd for C23H18IO2S (M + H)+ 485.0067, found 485.0074. (E)-2-Iodo-1,4-diphenyl-1-(methylsulfonyl)but-1-en-3-yne (7c). White solid; mp 102−103 °C; yield 54%. 1H NMR (300 MHz, CDCl3): δ 7.59−7.56 (m, 2H), 7.48−7.46 (m, 3H), 7.41−7.37 (m, 3H), 7.36−7.33 (m, 2H), 3.03(s, 3H). 13C NMR (125 MHz, CDCl3): δ 152.6, 138.0, 132.4, 130.7, 130.4, 130.0, 129.2, 129.0, 121.6, 108.0, 89.2, 89.1, 42.7. IR (KBr, ν, cm−1): 3012, 2175, 1438, 1313, 1132, 767, 538. HRMS m/z (ESI) calcd for C17H14IO2S (M + H)+ 408.9754, found 408.9758. (E)-2-Iodo-1,4-di(p-tolyl)-1-phenylsulfonylbut-1-en-3-yne (7d). Yellow solid; mp 115−116 °C; yield 69%. 1H NMR (300 MHz, CDCl3): δ 7.78 (d, J = 7.4 Hz, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.50 (d, J = 8.0 Hz, 2H), 7.42 (t, J = 7.6 Hz, 2H), 7.23 (d, J = 8.0 Hz, 2H), 7.16 (d, J = 7.8 Hz, 2H), 6.95 (d, J = 8.0 Hz, 2H), 2.41 (s, 3H), 2.37 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 152.2, 141.1, 140.3, 140.1, 135.5, 133.9, 132.3, 130.2, 129.7, 129.4, 129.2, 128.9, 119.0, 108.3, 90.3, 89.5, 22.1, 21.9. IR (KBr, ν, cm−1): 3064, 2194, 1327, 1149, 837, 569. HRMS m/z (ESI) calcd for C24H20IO2S (M + H)+ 499.0223, found 499.0229. (E)-2-Iodo-1,4-di(p-tolyl)-1-tosylbut-1-en-3-yne (7e). Yellow solid; mp 134−135 °C; yield 74%. 1H NMR (300 MHz, CDCl3): δ 7.66 (d, J = 8.0 Hz, 2H), 7.49 (d, J = 7.8 Hz, 2H), 7.23−7.21 (m, 4H), 7.16 (d, J = 7.7 Hz, 2H), 6.96 (d, J = 7.7 Hz, 2H), 2.41 (s, 3H), 2.39 (s, 3H), 2.38 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 152.6, 145.0, 141.0, 140.0, 137.3, 135.7, 132.3, 130.2, 129.9, 129.7, 129.4, 129.0, 119.1, 108.0, 89.9, 89.6, 22.1, 22.0, 21.9. IR (KBr, ν, cm−1): 3030, 2189, 1570, 1321, 1145, 817, 582. HRMS m/z (ESI) calcd for C25H22IO2S (M + H)+ 513.0380, found 513.0386. (E)-2-Iodo-1,4-di(p-tolyl)-1-methylsulfonylbut-1-en-3-yne (7f). Yellow solid; mp 152−153 °C; yield 67%. 1H NMR (300 MHz, CDCl3): δ 7.46 (d, J = 8.0 Hz, 2H), 7.29−7.18 (m, 6H), 3.03 (s, 3H), 2.41 (s, 3H), 2.39 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 151.7, 140.9, 140.2, 134.6, 131.9, 129.5, 129.4, 129.3, 118.2, 108.0, 89.0, 88.6, 42.3, 21.8, 21.6. IR (KBr, ν, cm−1): 3023, 2188, 1575, 1311, 1132, 825, 540. HRMS m/z 18012
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015
ACS Omega
■
toluene/H2O (v/v 2:1). After stirring at 45 °C for 2 h (monitored by TLC), the reaction mixture was quenched with saturated NaCl, extracted with ethyl acetate (3 × 10 mL), and dried over anhydrous Na2SO4. After filtration and concentrated in vacuo, the crude product was purified with flash chromatography on silica gel (petroleum ether/ethyl acetate = 20/1) to give product 8. (E)-3-Phenyl-2-(phenylsulfonyl)-1,3-di-p-tolylprop-2-en-1one (8). White solid; mp 170−171 °C; yield 94%. 1H NMR (300 MHz, CDCl3): δ 7.85 (d, J = 8.0 Hz, 2H), 7.49 (d, J = 7.5 Hz, 2H), 7.42 (t, J = 7.3 Hz, 1H), 7.28−7.16 (m, 5H), 7.13− 7.05 (m, 4H), 6.90 (d, J = 8.0 Hz, 2H), 6.80 (d, J = 8.0 Hz, 2H), 2.28 (s, 3H), 2.08 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 191.7, 154.9, 145.3, 141.9, 141.2, 134.0, 137.4, 136.2, 134.8, 133.4, 130.3, 129.9, 129.8, 129.5, 129.3, 129.0, 128.8, 128.6, 128.1, 22.2, 21.6. IR (KBr, ν, cm−1): 3057, 2918, 1662, 1604, 1319, 1305, 1251, 1149, 1085, 823, 738, 582, 528. HRMS m/z (ESI) calcd for C29H25O3S (M + H)+ 453.1519, found 453.1509. 1-Phenyl-2-(phenylsulfonyl)-3,3-di-p-tolylprop-2-en-1-ol (9). White solid; mp 186−187 °C; yield 92%. 1H NMR (300 MHz, CDCl3): δ 7.56 (d, J = 6.6 Hz, 2H), 7.40 (t, J = 7.23 Hz, 2H), 7.33−7.20 (m, 6H), 7.17−7.07 (m, 4H), 6.87−6.77 (m, 4H), 5.95 (d, J = 11.8 Hz, 1H), 4.86 (d, J = 11.8 Hz, 1H), 2.29 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 156.4, 142.7, 141.7, 141.5, 139.4, 138.5, 137.3, 135.6, 132.2, 129.9, 129.3, 128.9, 128.3, 127.9, 127.3, 127.2, 125.5, 73.6, 21.3, 21.2. IR (KBr, ν, cm−1): 3526, 3057, 3018, 2920, 1638, 1605, 1491, 1442, 816, 748, 698. HRMS m/z (ESI) calcd for C29H25O2S (M − OH) + 437.1570, found 437.1571. (Z)-(2-(p-Tolyl)-1-tosylbut-1-en-3-yne-1,4-diyl)dibenzene (10). White solid; mp 131−132 °C; yield 92%. 1H NMR (300 MHz, CDCl3): δ 7.74 (d, J = 7.7 Hz, 2H), 7.64−7.58 (m, 2H), 7.47−7.34 (m, 3H), 7.21−7.19 (m, 5H), 7.11−7.08 (m, 4H), 6.90 (d, J = 7.6 Hz, 2H), 2.38 (s, 3H), 2.21 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 146.9, 144.5, 139.0, 138.4, 135.1, 133.8, 133.7, 132.4, 132.2, 129.8, 129.7, 129.0, 128.9, 128.8, 128.4, 123.1, 104.8, 88.6, 22.1, 21.6. IR (KBr, ν, cm−1): 3041, 2198, 1600, 1298, 1143, 694, 576. HRMS m/z (ESI) calcd for C30H25O2S (M + H)+ 449.1570, found 449.1574.
■
ACKNOWLEDGMENTS We gratefully acknowledge the National Natural Science Foundation of China (Nos. 21272004 and 21702237) for financial support.
■
REFERENCES
(1) (a) Yin, W. H.; Liang, W. H.; Guo, L. P.; Lei, J. H.; Qiu, F. Y. G. Stereoselective Synthesis of Homofarnesenes: Establishment of an Efficient Method for the Stereoselective Preparation of Acyclic Tetrasubstituted Olefins. ACS Omega 2018, 3, 4551−4556. (b) Ganapathy, D.; Sekar, G. Efficient Synthesis of Polysubstituted Olefins Using Stable Palladium Nanocatalyst: Applications in Synthesis of Tamoxifen and Isocombretastatin A4. Org. Lett. 2014, 16, 3856−3859. (c) McKinley, N. F.; O’Shea, D. F. Carbolithiation of Diphenylacetylene as a Stereoselective Route to (Z)-Tamoxifen and Related Tetrasubstituted Olefins. J. Org. Chem. 2006, 71, 9552−9555. (d) Trost, B. M.; Papillon, J. P. N.; Nussbaumer, T. Ru-Catalyzed Alkene-Alkyne Coupling. Total Synthesis of Amphidinolide P. J. Am. Chem. Soc. 2005, 127, 17921−17937. (e) Williams, R. B.; Norris, A.; Slebodnick, C.; Merola, J.; Miller, J. S.; Andriantsiferana, R.; Rasamison, V. E.; Kingston, D. G. I. Cytotoxic Sesquiterpene Lactones from Vernonia pachyclada from the Madagascar Rainforest. J. Nat. Prod. 2005, 68, 1371−1374. (2) For recent reviews on polysubstituted alkene, see: (a) Dong, Z.; Ren, Z.; Thompson, S. J.; Xu, Y.; Dong, G. B. Transition-MetalCatalyzed C-H Alkylation Using Alkenes. Chem. Rev. 2017, 117, 9333−9403. (b) Kraft, S.; Ryan, K.; Kargbo, R. B. Recent Advances in Asymmetric Hydrogenation of Tetrasubstituted Olefins. J. Am. Chem. Soc. 2017, 139, 11630−11641. (c) Crossley, S. W. M.; Obradors, C.; Martinez, R. M.; Shenvi, R. A. Mn-, Fe-, and Co-Catalyzed Radical Hydrofunctionalizations of Olefins. Chem. Rev. 2016, 116, 8912− 9000. (d) Flynn, A. B.; Ogilvie, W. W. Stereocontrolled Synthesis of Tetrasubstituted Olefins. Chem. Rev. 2007, 107, 4698−4745. (3) (a) Cheng, L. J.; Mankad, N. P. Copper-Catalyzed Borocarbonylative Coupling of Internal Alkynes with Unactivated Alkyl Halides: Modular Synthesis of Tetrasubstituted β-Borylenones. Angew. Chem., Int. Ed. 2018, 57, 10328−10332. (b) Lim, N. K.; Weiss, P.; Li, B. X.; McCulley, C. H.; Hare, S. R.; Bensema, B. L.; Palazzo, T. A.; Tantillo, D. J.; Zhang, H. M.; Gosselin, F. Synthesis of Highly Stereodefined Tetrasubstituted Acyclic All-Carbon Olefins via a SynElimination Approach. Org. Lett. 2017, 19, 6212−6215. (4) For selected examples, see: (a) Lu, N.; Zhang, Z. G.; Ma, N. N.; Wu, C. H.; Zhang, G. S.; Liu, Q. F.; Liu, T. X. Copper-Catalyzed Difunctionalization of Allenes with Sulfonyl Iodides Leading to (E)-αIodomethyl Vinylsulfones. Org. Lett. 2018, 20, 4318−4322. (b) Fu, H.; Shang, J. Q.; Yang, T.; Shen, Y. H.; Gao, C. Z.; Li, Y. M. CopperCatalyzed Decarboxylative Disulfonylation of Alkynyl Carboxylic Acids with Sulfinic Acids. Org. Lett. 2018, 20, 489−492. (c) Suzol, S. H.; Howlader, A. H.; Wen, Z. W.; Ren, Y. U.; Laverde, E. E.; Garcia, C.; Liu, Y.; Wnuk, S. F. Pyrimidine Nucleosides with a Reactive (βChlorovinyl)sulfone or (β-Keto)sulfone Group at the C5 Position, Their Reactions with Nucleophiles and Electrophiles, and Their Polymerase-Catalyzed Incorporation into DNA. ACS Omega 2018, 3, 4276−4288. (d) García-Domínguez, A.; Müller, S.; Nevado, C. Nickel-Catalyzed Intermolecular Carbosulfonylation of Alkynes via Sulfonyl Radicals. Angew. Chem., Int. Ed. 2017, 56, 9949−9952. (e) Xiang, Y. C.; Kuang, Y. Y.; Wu, J. Generation of β-Halo Vinylsulfones through a Multicomponent Reaction with Insertion of Sulfur Dioxide. Chem. - Eur. J. 2017, 23, 6996−6999. (f) Fang, Y. Y.; Luo, Z. G.; Xu, X. M. Recent Advances in the Synthesis of Vinyl Sulfones. RSC Adv. 2016, 6, 59661−59676. (g) Singh, R.; Allam, B. K.; Singh, N.; Kumari, K.; Singh, S. K.; Singh, K. N. A Direct MetalFree Decarboxylative Sulfono Functionalization (DSF) of Cinnamic Acids to α,β-Unsaturated Phenyl Sulfones. Org. Lett. 2015, 17, 2656− 2659. (h) Newton, A. S.; Glória, P. M. C.; Gonçalves, L. M.; dos Santos, D. J. V. A.; Moreira, R.; Guedes, R. C.; Santos, M. M. M. Synthesis and Evaluation of Vinyl Sulfones as Caspase-3 Inhibitors. A Structure-Activity Study. Eur. J. Med. Chem. 2010, 45, 3858−3863.
ASSOCIATED CONTENT
S Supporting Information *
The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.8b02966. Experimental details, spectral and analytical data, and copies of 1H NMR and 13C NMR spectra for new compounds (PDF) X-ray data of 3a (CIF) X-ray data of 5c (CIF) X-ray data of 7i (CIF)
■
Article
AUTHOR INFORMATION
Corresponding Authors
*E-mail:
[email protected] (M.X.). *E-mail:
[email protected] (J.Z.). ORCID
Jitan Zhang: 0000-0002-8249-8329 Meihua Xie: 0000-0002-1921-790X Notes
The authors declare no competing financial interest. 18013
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015
ACS Omega
Article
Fragment Couplings and Macrocyclizations. J. Am. Chem. Soc. 2004, 126, 10682−10691. (13) For selected examples, see: (a) Shimkin, K. W.; Montgomery, J. Synthesis of Tetrasubstituted Alkenes by Tandem Metallacycle Formation/Cross-Electrophile Coupling. J. Am. Chem. Soc. 2018, 140, 7074−7078. (b) Huang, Y.; Huang, R. Z.; Zhao, Y. CobaltCatalyzed Enantioselective Vinylation of Activated Ketones and Imines. J. Am. Chem. Soc. 2016, 138, 6571−6576. (c) Nie, M.; Fu, W. Z.; Cao, Z. P.; Tang, W. J. Enantioselective Nickel-catalyzed Alkylative Alkyne−Aldehyde Cross-Couplings. Org. Chem. Front. 2015, 2, 1322−1325. (d) Bauer, T. Enantioselective dialkylzincmediated alkynylation, arylation and alkenylation of carbonyl groups. Coord. Chem. Rev. 2015, 299, 83−150. (e) Haynes, M. T.; Liu, P.; Baxter, R. D.; Nett, A. J.; Houk, K. N.; Montgomery, J. Dimer Involvement and Origin of Crossover in Nickel-Catalyzed AldehydeAlkyne Reductive Couplings. J. Am. Chem. Soc. 2014, 136, 17495− 17504. (f) Montgomery, J. Nickel-Catalyzed Cyclizations, Couplings, and Cycloadditions Involving Three Reactive Components. Acc. Chem. Res. 2000, 33, 467−473. (14) (a) Han, J. T.; Yun, J. Copper-Catalyzed Synthesis of Tetrasubstituted Enynylboronates via Chemo-, Regio-, and Stereoselective Borylalkynylation. Org. Lett. 2018, 20, 2104−2107. (b) Ye, C. Q.; Qian, B.; Li, Y. J.; Su, M.; Li, D. L.; Bao, H. L. Iron-Catalyzed Dehydrative Alkylation of Propargyl Alcohol with Alkyl Peroxides To Form Substituted 1,3-Enynes. Org. Lett. 2018, 20, 3202−3205. (c) Zhou, Y. J.; Zhang, Y.; Wang, J. B. Recent Advances in Transitionmetal-catalyzed Synthesis of Conjugated enynes. Org. Biomol. Chem. 2016, 14, 6638−6650. (d) Bharathiraja, G.; Sengoden, M.; Kannan, M.; Punniyamurthy, T. Expedient Synthesis of Tetrasubstituted Pyrroles via a Copper-Catalyzed Cascade Inter-/Intramolecular Cyclization of 1,3-Enynes Carry a Nitro Group with Amines. Org. Biomol. Chem. 2015, 13, 2786−2792. (e) Saito, S.; Yamamoto, Y. Recent Advances in the Transition-Metal-Catalyzed Regioselective Approaches to Polysubstituted Benzene Derivatives. Chem. Rev. 2000, 100, 2901−2915. (f) Nicolaou, K. C.; Dai, W. M.; Tsay, S. C.; Estevez, V. A.; Wrasidlo, W. Designed Enediynes: A New Class of DNA-Cleaving Molecules with Potent and Selective Anticancer Activity. Science 1992, 256, 1172−1178. (15) For selected examples, see: (a) Cheung, C. W.; Hu, X. L. Stereoselective Synthesis of Trisubstituted Alkenes through Sequential Iron-Catalyzed Reductive anti-Carbozincation of Terminal Alkynes and Base-Metal-Catalyzed Negishi Cross-Coupling. Chem. Eur. J. 2015, 21, 18439−18444. (b) Cornelissen, L.; Lefrancq, M.; Riant, O. Copper-Catalyzed Cross-Coupling of Vinylsiloxanes with Bromoalkynes: Synthesis of Enynes. Org. Lett. 2014, 16, 3024−3027. (c) Saha, D.; Chatterjee, T.; Mukherjee, M.; Ranu, B. C. Copper (I) Hydroxyapatite Catalyzed Sonogashira Reaction of Alkynes with Styrenyl Bromides. Reaction of cis-Styrenyl Bromides Forming Unsymmetric Diynes. J. Org. Chem. 2012, 77, 9379−9383. (d) Zhou, L.; Ye, F.; Ma, J. C.; Zhang, Y.; Wang, J. B. PalladiumCatalyzed Oxidative Cross-Coupling of N-Tosylhydrazones or Diazoesters with Terminal Alkynes: A Route to Conjugated Enynes. Angew. Chem. 2011, 123, 3572−3576. (e) Zhu, Y.; Li, T. Y.; Qu, X. M.; Sun, P.; Yang, H. L.; Mao, J. C. Copper(I)-Catalyzed Synthesis of 1,3-Enynes via Coupling between Vinyl Halides and Alkynes or Domino Coupling of Vinyl Halides. Org. Biomol. Chem. 2011, 9, 7309−7312. (f) Miyaura, N.; Suzuki, A. Palladium-Catalyzed CrossCoupling Reactions of Organoboron Compounds. Chem. Rev. 1995, 95, 2457−2483. (16) For selected examples, see: (a) Li, X.; Chen, X. L.; Zhang, Q.; Qu, L. B.; Bi, W. Z.; Sun, K.; Chen, J. Y.; Chen, X.; Zhao, Y. F. CuSO4-H-phosphonate Catalyzed Highly Stereo- and regioselective dimerization of terminal alkynes. RSC Adv. 2015, 5, 5004−5009. (b) Midya, G. C.; Parasar, B.; Dhara, K.; Dash, J. Ligand Mediated Iron Catalyzed Dimerization of Terminal Aryl Alkynes: Scope and Limitations. Org. Biomol. Chem. 2014, 12, 1812−1822. (c) Sakurada, T.; Sugiyama, Y.; Okamoto, S. Cobalt-Catalyzed Cross Addition of Silylacetylenes to Internal Alkynes. J. Org. Chem. 2013, 78, 3583− 3591. (d) Tsukada, N.; Ninomiya, S.; Aoyama, Y.; Inoue, Y.
(i) Meadows, D. C.; Sanchez, T.; Neamati, N.; North, T. W.; GervayHague, J. Ring Substituent Effects on Biological Activity of Vinyl Sulfones as Inhibitors of HIV-1. Bioorg. Med. Chem. 2007, 15, 1127− 1137. (j) Frankel, B. A.; Bentley, M.; Kruger, R. G.; McCafferty, D. G. Vinyl Sulfones: Inhibitors of SrtA, a Transpeptidase Required for Cell Wall Protein Anchoring and Virulence in Staphylococcus aureus. J. Am. Chem. Soc. 2004, 126, 3404−3405. (5) For selected examples, see: (a) Wan, J. P.; Hu, D. Q.; Bai, F. C.; Wei, L.; Liu, Y. Y. Stereoselective Z-Halosulfonylation of Terminal Alkynes using Sulfonohydrazides and CuX (X = Cl, Br, I). RSC Adv. 2016, 6, 73132−73135. (b) Li, X. Q.; Shi, X. H.; Fang, M. W.; Xu, X. S. Iron Halide-Mediated Regio- and Stereoselective Halosulfonylation of Terminal Alkynes with Sulfonylhydrazides: Synthesis of (E)-βChloro and Bromo Vinylsulfones. J. Org. Chem. 2013, 78, 9499−9504. (c) Zeng, X. M.; Ilies, L.; Nakamura, E. Iron-Catalyzed Regio- and Stereoselective Chlorosulfonylation of Terminal Alkynes with Aromatic Sulfonyl Chlorides. Org. Lett. 2012, 14, 954−956. (d) Liu, X. Y.; Duan, X. H.; Pan, Z. L.; Han, Y.; Liang, Y. M. Stereoselective Synthesis of (Z)-β-Chlorovinyl Sulfones by Addition of Sulfonyl Chlorides to Acetylenes. Synlett 2005, 11, 1752−1754. (6) (a) Hou, Y. L.; Zhu, L. Y.; Hu, H.; Chen, S. W.; Li, Z. F.; Liu, Y. J.; Gong, P. Iodine Promoted Iodosulfonylation of Alkynes with Sulfonyl Hydrazides in an Aqueous Medium: Highly Stereoselective Synthesis of (E)-β-Iodo Vinylsulfones. New J. Chem. 2018, 42, 8752− 8755. and references cited therein. (b) Yang, L.; Hu, D. Q.; Wei, L.; Liu, Y. Y. KI as Iodine Source for the Synthesis of E-Iodovinyl Sulfones via Metal-Free Iodosulfonylation of Terminal Alkynes. Phosphorus, Sulfur Silicon Relat. Elem. 2017, 192, 1301−1304. (7) Wei, W.; Wen, J. W.; Yang, D. S.; Jing, H. J.; You, J. M.; Wang, H. Direct Difunctionalization of Alkynes with Sulfinicacids and Molecular Iodine: a Simple and Convenient Approach to (E)-βIodovinyl Sulfones. RSC Adv. 2015, 5, 4416−4419. (8) Gao, Y.; Wu, W. Q.; Huang, Y. B.; Huang, K. F.; Jiang, H. F. NBS-Promoted Halosulfonylation of Terminal Alkynes: Highly Regio- and Stereoselective Synthesis of (E)-β-Halo Vinylsulfones. Org. Chem. Front. 2014, 1, 361−364. (9) Sun, Y. D.; Abdukader, A.; Lu, D.; Zhang, H. Y.; Liu, C. J. Synthesis of (E)-β-Iodo Vinylsulfones via Iodine Promoted Iodosulfonylation of Alkynes with Sodium Sulfinates in an Aqueous Medium at Room Temperature. Green Chem. 2017, 19, 1255−1258. (10) (a) Cui, H. H.; He, C. L.; Yang, D. S.; Yue, H. L.; Wei, W.; Wang, H. Direct Iodosulfonylation of Alkylynones with Sulfonylhydrazides and Iodine Pentoxide Leading to Multisubstituted αβEnones. Synlett 2018, 29, 830−834. (b) Kumar, R.; Dwivedi, V.; Reddy, M. S. Metal-Free Iodosulfonylation of Internal Alkynes: Stereodefined Access to Tetrasubstituted Olefins. Adv. Synth. Catal. 2017, 359, 2847−2856. (11) (a) Xie, M. H.; Wang, S. K.; Wang, J.; Fang, K.; Liu, C. Q.; Zha, C.; Jia, J. Construction of Substituted Benzenes via Pd-Catalyzed Cross-Coupling/Cyclization Reaction of Vinyl Halides and Terminal Alkynes. J. Org. Chem. 2016, 81, 3329−3334. (b) Xie, M. H.; Wang, J.; Fang, K.; Wang, S. K.; Yan, L. Q. Regio- and Stereoselective Synthesis of (E)-β-halo Alkenyl Ketones/Sulfones via Haloallylation of Alkynyl Ketones/Sulfones. Tetrahedron Lett. 2015, 56, 4388−4391. (12) For selected examples, see: (a) Kumar, G. S.; Kapur, M. Ruthenium-Catalyzed, Site-Selective C-H Allylation of Indoles with Allyl Alcohols as Coupling Partners. Org. Lett. 2016, 18, 1112−1115. (b) Mondal, K.; Mondal, B.; Pan, S. C. Organocatalytic Redox Isomerization of Electron-Deficient Allylic Alcohols: Synthesis of 1,4Ketoaldehydes. J. Org. Chem. 2016, 81, 4835−4840. (c) Ricard, S.; Sanapo, G. F.; Rahem, N.; Daoust, B. Synthesis of γ,δ-Unsaturated αAminoaldehydes Using a Copper Catalyzed Vinylation Reaction Followed by a Claisen Rearrangement. J. Org. Chem. 2016, 81, 5066− 5073. (d) Aursnes, M.; Tungen, J. E.; Colas, R. A.; Vlasakov, I.; Dalli, J.; Serhan, C. N.; Hansen, T. V. Synthesis of the 16S,17SEpoxyprotectin Intermediate in the Biosynthesis of Protectins by Human Macrophages. J. Nat. Prod. 2015, 78, 2924−2931. (e) Chan, J.; Jamison, T. F. Enantioselective Synthesis of (−)-Terpestacin and Structural Revision of Siccanol Using Catalytic Stereoselective 18014
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015
ACS Omega
Article
Palladium-Catalyzed Selective Cross-Addition of Triisopropylsilylacetylene to Internal and Terminal Unactivated Alkynes. Org. Lett. 2007, 9, 2919−2921. (e) Ghosh, R.; Zhang, X. W.; Achord, P.; Emge, T. J.; Krogh-Jespersen, K.; Goldman, A. S. Dimerization of Alkynes Promoted by a Pincer-Ligated Iridium Complex. C-C Reductive Elimination Inhibited by Steric Crowding. J. Am. Chem. Soc. 2007, 129, 853−866. (17) (a) Kong, K.; Moussa, Z.; Lee, C.; Romo, D. Total Synthesis of the Spirocyclic Imine Marine Toxin (−)-Gymnodimine and an Unnatural C4-Epimer. J. Am. Chem. Soc. 2011, 133, 19844−19856. (b) Takahashi, T.; Aoyagi, K.; Denisov, V.; Suzuki, N.; Choueiry, D.; Negishi, E. I. Zirconium Catalyzed C-C Bond Formation Reaction of Conjugated Diynes with EtMgBr. Tetrahedron Lett. 1993, 34, 8301− 8304. (c) Dabdoub, M. J.; Dabdoub, V. B.; Comasseto, J. V. Synthesis of (E)-l,4-Bis(organyl)but-1-en-3-ynes by Lithlium-Tellurium Exchange Reaction on (Z)-l-Butyltelluro-1,4-bis(organyl) But-1-en-3ynes. Tetrahedron Lett. 1992, 33, 2261−2264. (18) Teng, Q.; Xu, Y.; Liang, Y.; Wang, H.; Wang, Y.; Pan, Y. Transition Metal-Free Synthesis of 3-Alkynylpyrrole-2-carboxylates via Michael Addition/Intramolecular Cyclodehydration. Adv. Synth. Catal. 2016, 358, 1897−1902. (19) Niu, X. J.; Li, C. J.; Li, J.; Jia, X. S. Importance of Bases on the Copper-Catalyzed Oxidative Homocoupling of Terminal Alkynes to 1,4-Disubstituted 1,3-Diynes. Tetrahedron Lett. 2012, 53, 5559−5561.
18015
DOI: 10.1021/acsomega.8b02966 ACS Omega 2018, 3, 18002−18015